Document:

Exhibit 4.3

 

Courtside
Group, Inc.

(dba
podcastone)

WARRANT TO PURCHASE SHARES OF COMMON STOCK

 

THIS WARRANT AND THE SECURITIES ISSUABLE UPON
EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR
QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED
OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SHARES IS EFFECTIVE UNDER THE SECURITIES ACT AND IS QUALIFIED UNDER APPLICABLE
STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS UNDER THE SECURITIES
ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND, IF THE CORPORATION REQUESTS, AN OPINION OF COUNSEL,
WHICH COUNSEL AND OPINION ARE SATISFACTORY TO THE COMPANY, THAT SUCH REQUIREMENTS HAVE BEEN SATISFIED AS DETERMINED BY THE CORPORATION.

 

Original Issue Date: July 15, 2022

Expiration Date: January 15, 2028

 

FOR VALUE RECEIVED, Courtside
Group, Inc. (dba PodcastOne), a company incorporated under the laws of Delaware (the “Company”), hereby certifies that
[NAME], or its registered assigns (the “Holder”) is entitled to purchase from the Company a number of duly authorized,
validly issued, fully paid and nonassessable Warrant Shares subject to the terms, conditions and adjustments set forth below in this Warrant.
Certain capitalized terms used herein are defined in Section 1 hereof.

 

This Warrant is one of a series of Warrants issued
by the Company pursuant to the Company’s private offering described in the Subscription Booklet of the Company dated July 2022 (as
amended, modified or supplemented from time to time and including the annexes thereto, the “Subscription Booklet”)
and the related Subscription Agreements (each a “Subscription Agreement” and collectively, the “Subscription
Agreements”).

 

1. Definitions.
As used in this Warrant, the following terms have the respective meanings set forth below:

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

 

“Aggregate
Exercise Price” means an amount equal to the product of (a) the number of Warrant Shares in respect of which this Warrant is
then being exercised pursuant to Section 3 hereof, multiplied by (b) the Exercise Price in effect as of the Exercise Date in accordance
with the terms of this Warrant.

 

“Board”
means the board of directors of the Company.

 

     

     

    

 

“Business
Day” means any day, except a Saturday, Sunday or legal holiday, on which banking institutions in the city of New York, New York
are authorized or obligated by law or executive order to close.

 

“Commission”
means the U. S. Securities and Exchange Commission or any other applicable federal agency at the time administering the Securities Act.

 

“Common
Stock” means the common stock of the Company, par value $0.00001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.

 

“Conversion
Price of the Note” shall mean the conversion price of the Notes as defined therein.

 

“Convertible
Securities” means any securities (directly or indirectly) convertible into or exchangeable for Common Stock, but excluding Options.

 

“Excluded
Issuances” means any issuance or sale (or deemed issuance or sale) by the Company after the Original Issue Date of: (a) Common
Stock issued upon the exercise of this Warrant or the other Warrants or the Notes; (b) Common Stock (as such number of shares is equitably
adjusted for subsequent share splits, share combinations, share dividends and recapitalizations) issued directly or upon the exercise
of Options or upon the settlement of any securities issued to directors, officers, employees, consultants, agents or representatives of
the Company in connection with their service as directors of the Company, their employment by the Company, their retention as consultants
by the Company or services provided by them to the Company, in each case authorized by the Board and issued pursuant to any approved equity
incentive plans or other employee compensation plans of the Company (as such maybe adopted, amended, modified or restated from time to
time) (collectively, the “Equity Plans”) (including all such Common Stock and Options outstanding prior to the Original
Issue Date); (c) Common Stock issued to consultants, vendors, partners, suppliers or talent pursuant to any consulting or other agreements
(d) Common Stock issued upon the conversion or exercise of Options (other than Options covered by clause (b) above) or upon settlement
of any securities issued under the Equity Plans or Convertible Securities issued prior to the Original Issue Date (including all of the
Notes issued as part of the same unit as this Warrant) or Common Stock issued in exchange or conversion of Convertible Securities issued
prior to the Original Issue Date (including all of the Notes issued as part of the same unit as this Warrant and the other Warrants and
Notes), provided, that other than with respect to any Common Stock issued pursuant to the Equity Plans or the Warrants or the Notes, such
securities are not amended after the date hereof to increase the number of Common Stock issuable thereunder or to lower the exercise or
conversion price thereof; (e) Common Stock, Options or Convertible Securities issued (i) to persons in connection with a joint venture,
talent and/or podcast acquisition, strategic alliance or other commercial or collaborative relationship with such person (including persons
that are customers, suppliers, vendors and strategic partners of the Company) relating to the operation of the Company’s business
and not for the primary purpose of raising equity capital, (ii) in connection with a transaction in which the Company, directly or indirectly,
acquires another business or its tangible or intangible assets or the acquisition or license by the Company and/or an of its subsidiaries
of the securities, businesses, property or other assets of another person, or (iii) to lenders as equity kickers in connection with debt
financings of the Company, in each case where such transactions have been approved by the Board; (f) Common Stock in an offering for cash
for the account of the Company that is underwritten on a best efforts or firm commitment basis and is registered with the U.S. Securities
and Exchange Commission under the Securities Act; (g) shares of Common Stock, Options or Convertible Securities issued to the lessor or
vendor in any office lease or equipment lease or similar equipment financing transaction in which the Company obtains the use of such
office space or equipment for its business; (h) any issuances to any underwriters or placements agents as equity compensation in connection
with their services provided to the Company; (i) any securities issued in the Qualified Financing or the Qualified Event, as applicable;
or (j) any securities issued to the Company’s parent, LiveOne, in connection with anticipated spinout of such securities to LiveOne’s
stockholders, or any internal recapitalization or reorganization of the Company, in connection with the Qualified Financing or Qualified
Event, as applicable.

 

    2

     

    

 

“Exercise
Date” means, for any given exercise of this Warrant, the date on which the conditions to such exercise as set forth in Section
3 shall have been satisfied at or prior to 5:00 p.m., New York, New York time, on a Business Day, including, without limitation, the receipt
by the Company of the Exercise Agreement, the Warrant and the Aggregate Exercise Price.

 

“Exercise
Agreement” has the meaning set forth in Section 3(a)(i).

 

“Exercise
Period” has the meaning set forth in Section 2.

 

“Exercise
Price” means: (a) if a Qualified Financing or the Qualified Event, as applicable, has occurred on or before the Maturity Date,
the lower of (i) the quotient of (x) the Valuation Cap divided by (y) the Fully Diluted Capitalization immediately prior to the Qualified
Financing or the Qualified Event, as applicable, and (ii) the price per share or other whole unit, as applicable, in the Qualified Financing
or the Qualified Event, as applicable, or (b) if a Qualified Financing or the Qualified Event, as applicable, has not occurred on or before
the Maturity Date, the Voluntary Conversion Price (as defined in the Notes).

 

“Fair Market
Value” means, as of any particular date: (a) the volume weighted average of the closing sales prices of the Common Stock for
such day on all domestic securities exchanges on which the Common Stock may at the time be listed; (b) if there have been no sales of
the Common Stock on any such exchange on any such day, the average of the highest bid and lowest asked prices for the Common Stock on
all such exchanges at the end of such day; (c) if on any such day the Common Stock is not listed on a domestic securities exchange, the
closing sales price of the Common Stock as quoted on the OTC Markets or similar quotation system or association for such day; or (d) if
there have been no sales of the Common Stock on such a quotation system or association on such day, the average of the highest bid and
lowest asked prices for the Common Stock quoted on the OTC Markets or similar quotation system or association for such day; in each case,
averaged over ten (10) consecutive Business Days ending on the Business Day immediately prior to the day as of which “Fair Market
Value” is being determined. If at any time the Common Stock is not listed on any domestic securities exchange or quoted on the OTC
Markets or similar quotation system or association, the “Fair Market Value” of the Common Stock shall be the fair market value
per share as determined jointly by the Board and a majority of the holders that hold notes of the series of notes issued on the Original
Issue Date of like tenor as this Note; provided, that if the Board and the Holder are unable to agree on the fair market value per share
of the Common Stock within a reasonable period of time (not to exceed thirty (30) days from the Company’s receipt of the Exercise
Agreement), such fair market value shall be determined by a nationally recognized investment banking, accounting or valuation firm engaged
by the Company. The determination of such firm shall be final and conclusive, and the fees and expenses of such valuation firm shall be
borne equally by the Company and the Holder.

 

    3

     

    

 

“Fully
Diluted Capitalization” means the number of outstanding shares of Common Stock, assuming conversion of all outstanding securities
convertible into shares of Common Stock and exercise of all outstanding options and warrants to purchase shares of Common Stock or other
outstanding securities convertible into shares of Common Stock, but excluding, for this purpose, (i) the conversion of any Notes (whether
or not such Notes have actually been converted), (ii) the exercise of any Warrants (whether or not such Warrants have actually been exercised),
(iii) the exercise of any warrants issued to the Placement Agent (as defined in the Subscription Agreement) or any other placement agent
or underwriter in connection with securities offered pursuant to the Subscription Booklet or in the Qualified Financing or the Qualified
Event, as applicable), and (iv) any securities issued in connection with the Qualified Financing or the Qualified Event, as applicable
(including, without limitation, pursuant to any equity incentive plans); provided that in the case of a Qualified Financing or the Qualified
Event, as applicable, “Fully Diluted Capitalization” also shall exclude the shares of Common Stock that are issued or reserved
for issuance under the Company’s existing or future equity incentive plans or any equity incentive plans to be adopted in connection
with the offering of the Notes or the Qualified Financing or the Qualified Event, as applicable, as the case may be.

 

“Holder”
has the meaning set forth in the preamble.

 

“Maturity
Date” has the meaning set forth in the Notes.

 

“Nasdaq”
means The Nasdaq Stock Market LLC.

 

“Notes”
mean all of the Original Issue Discount Convertible Promissory Notes of the Company that are being offered and sold pursuant to the Subscription
Booklet and related Subscription Agreements.

 

“Options”
means any warrants or other rights or options to subscribe for or purchase Common Stock or any other capital stock of the Company or Convertible
Securities.

 

“Original
Issue Date” means July 15, 2022.

 

“OTC Markets”
means the OTC Markets Group Inc. electronic interdealer quotation system, including the OTCQX, OTCQB and OTC Pink Marketplaces.

 

    4

     

    

 

“Qualified
Event” means the direct listing of the Company’s securities on a national securities exchange.

 

“Qualified
Financing” means the closing of an underwritten public offering of Common Stock or units consisting of Common Stock and warrants
to purchase Common Stock which results in the Common Stock being traded on a national securities exchange.

 

“Person”
means any individual, sole proprietorship, partnership, limited liability company, corporation, joint venture, trust, incorporated organization
or government or department or agency thereof

 

“Rule 144”
means Rule 144 promulgated by the Commission under the Securities Act.

 

“Securities
Act” means the Securities Act of 1933, as amended, or any similar federal statute promulgated in replacement thereof, and the
rules and regulations of the Commission thereunder, all as the same shall be in effect at the time.

 

“Valuation
Cap” means $60,000,000.

 

“Warrant”
means this Warrant and all warrants issued upon division or combination of, or in substitution for, this Warrant.

 

“Warrant
Shares” means the shares of Common Stock or other capital stock of the Company then issuable or purchasable upon exercise of
this Warrant in accordance with the terms of this Warrant. Specifically, the number of Warrant Shares issuable upon exercise of this Warrant
shall equal to the quotient obtained by dividing (i) $___________ [100% of the Principal Amount of Note purchased by the Holder]
by (ii) the quotient of (i) the Valuation Cap divided by (ii) the Fully Diluted Capitalization immediately prior to the Qualified Financing
or the Qualified Event, as applicable. All of the foregoing is subject to adjustment on the terms contained herein.

 

2. Term of Warrant.
Subject to the terms and conditions hereof, at any time or from time to time after the date that is one calendar year from the Original
Issue Date and prior to 5:00 p.m., New York, New York time, on [DATE], 20281 or, if such day is not a Business Day, on the
next preceding Business Day (the “Exercise Period”), the Holder of this Warrant may exercise this Warrant for all
or any part of the Warrant Shares purchasable hereunder (subject to adjustment as provided herein).

 

3. Exercise
of Warrant.

 

(a) Exercise
Procedure. This Warrant may be exercised from time to time on any Business Day during the Exercise Period, for all or any part of
the unexercised Warrant Shares, upon:

 

(i) surrender
of this Warrant to the Company at its then principal executive offices (or an indemnification undertaking with respect to this Warrant
in the case of its loss, theft or destruction), together with an Exercise Agreement in the form attached hereto as Exhibit A (each, an
“Exercise Agreement”), duly completed (including specifying the number of Warrant Shares to be purchased) and executed; and

 

(ii) payment
to the Company of the Aggregate Exercise Price in accordance with Section 3(b).

 

 

		1	Insert the date that is the 5.5 year anniversary of the Original
Issue Date.

 

    5

     

    

 

(b) Payment
of the Aggregate Exercise Price. Payment of the Aggregate Exercise Price shall be made, at the option of the Holder as expressed in
the Exercise Agreement, by the following methods:

 

(i) by
delivery to the Company of a certified or official bank check

payable to the order of the Company or by wire transfer of immediately available funds to an account designated in writing by the Company,
in the amount of such Aggregate Exercise Price; or

 

(ii) only
in the event that a Registration Statement covering the resale

of the Warrant Shares by Holder is not effective with the Commission as of a date that is within six (6) months after the date upon which
a Qualified Financing or Qualified Event, as applicable, is consummated, a Holder may instruct the Company to issue Warrant Shares then
issuable upon exercise of all or any part of this Warrant on a net basis such that, without payment of any cash consideration or other
immediately available funds, the Holder shall surrender this Warrant in exchange for the number of Warrant Shares as is computed using
the following formula:

 

Where:

 

X = the number of Warrant Shares to
be issued to the Holder.

 

Y = the total number of Warrant Shares
for which the Holder has elected to exercise this Warrant pursuant to Section 3(a).

 

A = the Fair Market Value of one Warrant
Share as of the applicable Exercise Date.

 

B = the Exercise Price in effect under
this Warrant as of the applicable Exercise Date.

 

X = Y(A - B) ± A

 

(iii) by
surrendering to the Company (x) Warrant Shares previously acquired by the Holder with an aggregate Fair Market Value as of the Exercise
Date equal to such Aggregate Exercise Price and/or (y) other securities of the Company having a value as of the Exercise Date equal to
the Aggregate Exercise Price (which value in the case of debt securities shall be the principal amount thereof plus accrued and unpaid
interest, in the case of preferred shares shall be the liquidation value thereof plus accumulated and unpaid dividends and in the case
of shares of Common Stock shall be the Fair Market Value thereof); or

 

(iv) any
combination of the foregoing.

 

    6

     

    

 

In the event of
any withholding of Warrant Shares or surrender of other equity securities pursuant to clause (ii), (iii) or (iv) above where the number
of shares whose value is equal to the Aggregate Exercise Price is not a whole number, the number of shares withheld by or surrendered
to the Company shall be rounded up to the nearest whole share and the Company shall make a cash payment to the Holder (by delivery of
a certified or official bank check or by wire transfer of immediately available funds) based on the incremental fraction of a share being
so withheld by or surrendered to the Company in an amount equal to the product of (x) such incremental fraction of a share being so withheld
or surrendered multiplied by (y) in the case of Common Stock, the Fair Market Value per Warrant Share as of the Exercise Date, and, in
all other cases, the value thereof as of the Exercise Date determined in accordance with clause (iii)(y) above.

 

(c) Delivery
of Share Certificates. Upon receipt by the Company of the Exercise Agreement, surrender of this Warrant and payment of the Aggregate
Exercise Price (in accordance with Section 3 hereof), the Company shall, as promptly as practicable, and in any event within ten (10)
Business Days thereafter, execute (or cause to be executed) and deliver (or cause to be delivered) to the Holder either statement of position
or a certificate or certificates representing the Warrant Shares issuable upon such exercise, as determined by the Company unless requested
otherwise by the Holder. If applicable, the share certificate or certificates so delivered shall be, to the extent possible, in such denomination
or denominations as the exercising Holder shall reasonably request in the Exercise Agreement and shall be registered in the name of the
Holder or, subject to compliance with Section 5 below, such other Person’s name as shall be designated in the Exercise Agreement.
This Warrant shall be deemed to have been exercised and such statement of position pr certificate or certificates of Warrant Shares shall
be deemed to have been delivered or issued, as applicable, and the Holder or any other Person so designated to be named therein shall
be deemed to have become a holder of record of such Warrant Shares for all purposes, as of the Exercise Date.

 

(d) Fractional
Shares. The Company shall not be required to issue a fractional Warrant Share upon exercise of any Warrant. As to any fraction of
a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall round up to the next whole share.

 

(e) Delivery
of New Warrant. Subject to Section 7(a), unless the purchase rights represented by this Warrant shall have expired or shall have been
fully exercised, the Company shall, at the time of delivery of the certificate or certificates representing the Warrant Shares being issued
in accordance with Section 3(c) hereof, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unexpired
and unexercised Warrant Shares called for by this Warrant. Such new Warrant shall in all other respects be identical to this Warrant.

 

    7

     

    

 

(f) Valid
Issuance of Warrant and Warrant Shares; Payment of Taxes. With respect to the exercise of this Warrant, the Company hereby represents,
covenants and agrees:

 

(i) This
Warrant is, and any Warrant issued in substitution for or replacement of this Warrant shall be, upon issuance, duly authorized and validly
issued.

 

(ii) All
Warrant Shares issuable upon the exercise of this Warrant pursuant to the terms hereof shall be, upon issuance, and the Company shall
take all such actions as may be necessary or appropriate in order that such Warrant Shares are, validly issued, fully paid and non-assessable,
issued without violation of any preemptive or similar rights of any shareholder of the Company and free and clear of all taxes, liens
and charges.

 

(iii) The
Company shall take all such actions as may be necessary to ensure that all such Warrant Shares are issued without violation by the Company
of any applicable law or governmental regulation or any requirements of any domestic securities exchange upon which Common Stock or other
securities constituting Warrant Shares may be listed at the time of such exercise (except for official notice of issuance which shall
be immediately delivered by the Company upon each such issuance).

 

(iv) The
Company shall use its best efforts to cause the Warrant Shares, immediately upon such exercise, to be listed on any domestic securities
exchange upon which Common Stock or other securities constituting Warrant Shares are listed at the time of such exercise.

 

(v) The
Company shall pay all expenses in connection with, and all taxes (other than income taxes) and other governmental charges that may be
imposed with respect to, the issuance or delivery of Warrant Shares upon exercise of this Warrant; provided, that the Company shall not
be required to pay any tax or governmental charge that may be imposed with respect to any applicable withholding or the issuance or delivery
of the Warrant Shares to any Person other than the Holder, and no such issuance or delivery shall be made unless and until the Person
requesting such issuance has paid to the Company the amount of any such tax, or has established to the satisfaction of the Company that
such tax has been paid.

 

(g) Conditional
Exercise. Notwithstanding any other provision hereof, if an exercise of any portion of this Warrant is to be made in connection with
a public offering or a sale of the Company (pursuant to a merger, sale of shares, or otherwise in which control of the Company is transferred),
such exercise may at the election of the Holder be conditioned upon the consummation of such transaction, in which case such exercise
shall not be deemed to be effective until immediately prior to the consummation of such transaction.

 

    8

     

    

 

(h) Reservation
of Shares. During the Exercise Period, the Company shall at all times reserve and keep available out of its authorized but unissued
Common Stock or other securities constituting Warrant Shares, solely for the purpose of issuance upon the exercise of this Warrant, the
maximum number of Warrant Shares issuable upon the exercise of this Warrant.

 

(i) Holder’s
Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 3 or otherwise, to the extent that after giving effect to such issuance after exercise
by the Holder, the Holder (together with the Holder’s Affiliates, and any other Persons acting as a group together with the Holder
or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)), would beneficially own in excess of
the Beneficial Ownership Limitation (as defined below).  For purposes of the foregoing sentence, the number of shares of Common Stock
beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable
upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common
Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder
or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or unconverted portion of any other
securities of the Company subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially
owned by the Holder or any of its Affiliates or Attribution Parties.  Except as set forth in the preceding sentence, for purposes
of this Section 3(i), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and
regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation
is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in
accordance therewith. To the extent that the limitation contained in this Section 3(i) applies, the determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which
portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall
be deemed to be the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by the
Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject
to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.
In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the
Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 3(i), in determining the number of outstanding
shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s
most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company
or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon
the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number
of shares of Common Stock then outstanding.  In any case, the number of outstanding shares of Common Stock shall be determined after
giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution
Parties since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership
Limitation” shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance
of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the
Beneficial Ownership Limitation provisions of this Section 3(i), provided that the Beneficial Ownership Limitation in no event exceeds
9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock
upon exercise of this Warrant held by the Holder and the provisions of this Section 3(i) shall continue to apply. Any increase in the
Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. The
provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this
Section 3(i) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership
Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations
contained in this paragraph shall apply to a successor holder of this Warrant.

 

    9

     

    

 

4. Adjustment
to Exercise Price and Number of Warrant Shares.

 

(a) Price
Protection. Except as provided in (x) Section 4(c) and (y) in the case of an event described in either Section 4(d) or Section 4(e),
if the Company shall, at any time after the Original Issue Date and until the earlier of (i) ten (10) days following the Maturity Date
or (ii) the date upon which a Qualified Financing or Qualified Event, as applicable, if any, is consummated, issue or sell, or in accordance
with Section 4(d) is deemed to have issued or sold, any Common Stock without consideration or for consideration per share less than the
Exercise Price in effect immediately prior to such issuance or sale (or deemed issuance or sale), then immediately upon such issuance
or sale (or deemed issuance or sale), the Exercise Price in effect immediately prior to such issuance or sale (or deemed issuance or sale)
shall be reduced (and in no event increased) to an Exercise Price equal to the lowest price per share at which any such share of Common
Stock has been issued or sold (or is deemed to have been issued or sold); provided, that if such issuance or sale (or deemed issuance
or sale) was without consideration, then the Company shall be deemed to have received an aggregate of $0.001 of consideration for all
such shares so issued or deemed to be issued.

 

(b) Adjustment
to Number of Warrant Shares. If there is no effective Registration Statement covering the resale of the Warrant Shares by the Holder
as of a date that is within 90 days after the closing date of the Qualified Financing or Qualified Event, as applicable, if any (the “Trigger
Date”), then exercise of this Warrant may be made by the cashless exercise procedure specified in Section 3(b)(ii) and the number
of Warrant Shares issuable upon the exercise of this Warrant immediately prior to the Trigger Date shall be increased to a number of Warrant
Shares equal to the sum of (A) the number of Warrant Shares issuable upon the exercise of this Warrant immediately prior to the Trigger
Date plus (B) the product obtained by multiplying (x) the number of Warrant Shares issuable upon the exercise of this Warrant immediately
prior to the Trigger Date by (y) 0.05. Additionally, on every monthly anniversary of the Trigger Date and until the earlier of (i) there
is an effective Registration Statement covering the resale of the Warrant Shares by the Holder and (ii) the date on which the Warrant
Shares are Rule 144 eligible, the number of Warrant Shares issuable upon the exercise of this Warrant shall be increased to a number of
Warrant Shares equal to the sum of (i) the number of Warrant Shares issuable upon the exercise of this Warrant immediately prior to such
monthly anniversary plus (ii) the product obtained by multiplying (a) the number of Warrant Shares issuable upon the exercise of this
Warrant immediately prior to the Trigger Date (minus any Warrants that have been exercised prior to such monthly anniversary) by (b) 0.05,
with such amount pro-rated for any partial months.

 

    10

     

    

 

(c) Exceptions
To Adjustment Upon Issuance of Common Stock. Anything herein to the contrary notwithstanding, there shall be no adjustment to the
Exercise Price and Sections 4(a), (b), (d), (e), (f) and (g) shall not apply with respect to any Excluded Issuance.

 

(d) Adjustment
to Exercise Price and Warrant Shares Upon Dividend, Subdivision or Combination of Common Stock. If the Company shall, at any time
or from time to time after the Original Issue Date, (i) pay a dividend or make any other distribution upon the Common Stock or any other
capital stock of the Company payable in Common Stock or in Options or Convertible Securities, or (ii) subdivide (by any stock split, recapitalization
or otherwise) its outstanding shares of Common Stock into a greater number of shares, the Exercise Price in effect immediately prior to
any such dividend, distribution or subdivision shall be proportionately reduced and the number of Common Stock issuable upon exercise
of this Warrant shall be proportionately increased. If the Company at any time combines (by combination, reverse stock split or otherwise)
its outstanding Common Stock into a smaller number of shares, the Exercise Price in effect immediately prior to such combination shall
be proportionately increased and the number of Warrant Shares issuable upon exercise of this Warrant shall be proportionately decreased.
Any adjustment under this Section 4(a) shall become effective at the close of business on the date the dividend, subdivision or combination
becomes effective.

 

(e) Adjustment
to Exercise Price and Warrant Shares Upon Reorganization, Reclassification, Consolidation or Merger. In the event of any (i) capital
reorganization of the Company, (ii) reclassification of the shares of the Company (other than a change in par value or from par value
to no par value or from no par value to par value or as a result of a share dividend or subdivision, split-up or combination of shares),
(iii) consolidation or merger of the Company with or into another Person, (iv) sale of all or substantially all of the Company’s
assets to another Person, or (v) other similar transaction (other than any such transaction covered by Section 4(a)), in each case which
entitles the holders of Common Stock to receive (either directly or upon subsequent liquidation) stock, securities or assets with respect
to or in exchange for Common Stock, each Warrant shall, immediately after such reorganization, reclassification, consolidation, merger,
sale or similar transaction, remain outstanding and shall thereafter, in lieu of or in addition to (as the case may be) the number of
Warrant Shares then exercisable under this Warrant, be exercisable for the kind and number of shares or other securities or assets of
the Company or of the successor Person resulting from such transaction to which the Holder would have been entitled upon such reorganization,
reclassification, consolidation, merger, sale or similar transaction if the Holder had exercised this Warrant in full immediately prior
to the time of such reorganization, reclassification, consolidation, merger, sale or similar transaction and acquired the applicable number
of Warrant Shares then issuable hereunder as a result of such exercise (without taking into account any limitations or restrictions on
the exercisability of this Warrant); and, in such case, appropriate adjustment (in form and substance satisfactory to the Holder) shall
be made with respect to the Holder’s rights under this Warrant to insure that the provisions of this Section 4 hereof shall thereafter
be applicable, as nearly as possible, to this Warrant in relation to any shares, securities or assets thereafter acquirable upon exercise
of this Warrant (including, in the case of any consolidation, merger, sale or similar transaction in which the successor or purchasing
Person is other than the Company, an immediate adjustment in the Exercise Price to the value per share for the Common Stock reflected
by the terms of such consolidation, merger, sale or similar transaction, and a corresponding immediate adjustment to the number of Warrant
Shares acquirable upon exercise of this Warrant without regard to any limitations or restrictions on exercise, if the value so reflected
is less than the Exercise Price in effect immediately prior to such consolidation, merger, sale or similar transaction). The provisions
of this Section 4(e) shall similarly apply to successive reorganizations, reclassifications, consolidations, mergers, sales or similar
transactions. The Company shall not effect any such reorganization, reclassification, consolidation, merger, sale or similar transaction
unless, prior to the consummation thereof, the successor Person (if other than the Company) resulting from such reorganization, reclassification,
consolidation, merger, sale or similar transaction, shall assume, by written instrument substantially similar in form and substance to
this Warrant and satisfactory to the Holder, the obligation to deliver to the Holder such shares, securities or assets which, in accordance
with the foregoing provisions, such Holder shall be entitled to receive upon exercise of this Warrant.

 

    11

     

    

 

(f) Certificate
as to Adjustment.

 

(i) As
promptly as reasonably practicable following any adjustment of the Exercise Price, but in any event not later than ten (10) Business Days
thereafter, the Company shall furnish to the Holder a certificate of an executive officer setting forth in reasonable detail such adjustment
and the facts upon which it is based and certifying the calculation thereof

 

(ii) As
promptly as reasonably practicable following the receipt by the Company of a written request by the Holder, but in any event not later
than ten (10) Business Days thereafter, the Company shall furnish to the Holder a certificate of an executive officer certifying the Exercise
Price then in effect and the number of Warrant Shares or the amount, if any, of other shares, securities or assets then issuable upon
exercise of the Warrant.

 

(g) Notices.
In the event:

 

(i) that
the Company shall take a record of the holders of its Common Stock (or other capital stock or securities at the time issuable upon exercise
of the Warrant) for the purpose of entitling or enabling them to receive any dividend or other distribution, to vote at a meeting (or
by written consent), to receive any right to subscribe for or purchase any shares of capital stock of any class or any other securities,
or to receive any other security; or

 

(ii) of
any capital reorganization of the Company, any reclassification of the Common Stock of the Company, any consolidation or merger of the
Company with or into another Person, or sale of all or substantially all of the Company’s assets to another Person; or

 

(iii) of
the voluntary or involuntary dissolution, liquidation or winding- up of the Company;

 

then, and in each
such case, the Company shall send or cause to be sent to the Holder at least ten (10) days prior to the applicable record date or the
applicable expected effective date, as the case may be, for the event, a written notice specifying, as the case may be, (A) the record
date for such dividend, distribution, meeting or consent or other right or action, and a description of such dividend, distribution or
other right or action to be taken at such meeting or by written consent, or (B) the effective date on which such reorganization, reclassification,
consolidation, merger, sale, dissolution, liquidation or winding-up is proposed to take place, and the date, if any is to be fixed, as
of which the books of the Company shall close or a record shall be taken with respect to which the holders of record of Common Stock (or
such other capital stock or securities at the time issuable upon exercise of the Warrant) shall be entitled to exchange their Common Stock
(or such other capital stock or securities) for securities or other property deliverable upon such reorganization, reclassification, consolidation,
merger, sale, dissolution, liquidation or winding-up, and the amount per share and character of such exchange applicable to the Warrant
and the Warrant Shares.

 

    12

     

    

 

5. Transfer
of Warrant. Subject to the transfer conditions referred to in the legend endorsed hereon, this Warrant and all rights hereunder are
transferable, in whole or in part, by the Holder without charge to the Holder, upon surrender of this Warrant to the Company at its then
principal executive offices with a properly completed and duly executed Assignment in the form attached hereto as Exhibit B, together
with funds sufficient to pay any transfer taxes described in Section 3(f)(v) in connection with the making of such transfer. Upon such
compliance, surrender and delivery and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in
the name of the assignee or assignees and in the denominations specified in such instrument of assignment, and shall issue to the assignor
a new Warrant evidencing the portion of this Warrant, if any, not so assigned and this Warrant shall promptly be cancelled.

 

The Holder agrees
not to make any disposition of all or any of this Warrant or Warrants Shares unless and until the transferee has agreed in writing for
the benefit of the Company to the undertaking set out in Section 5 and:

 

(i) there
is then in effect a registration statement under the Securities Act covering such proposed disposition, and such disposition is made in
connection with such registration statement; or

 

(ii) the
Holder has (A) notified the Company of the proposed disposition; (B) furnished the Company with a detailed statement of the circumstances
surrounding the proposed disposition; and (C) if requested by the Company, furnished the Company with an opinion of counsel, which opinion
and counsel are reasonably satisfactory to the Company, that such disposition will not require registration under the Securities Act.

 

The Holder agrees not to make any disposition
of all or any of this Warrant or Warrants Shares to the Company’s competitors, as determined in good faith by the Company.

 

    13

     

    

 

6. Fundamental
Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one
or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company
or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other
securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or 50% or more of the
voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in
one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation,
a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other
Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or more of the voting power of the common equity
of the Company (each a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall
have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence
of such Fundamental Transaction, at the option of the Holder, the number of shares of Common Stock of the successor or acquiring corporation
or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable
immediately prior to such Fundamental Transaction; provided, that this Section 6 shall not apply to any triggering event as a result of
the conversion of the Notes, exercise of the Warrants and/or as a result of the Qualified Financing or Qualified Event. For purposes of
any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based
on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company
shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different
components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be
received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon
any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event a Fundamental
Transaction  is consummated on or prior to the time of a Qualified Financing or Qualified Event, the Company or any Successor Entity
(as defined below) shall, at the Holder’s option, exercisable at any time concurrently with, or within fifteen (15) days after,
the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction),
purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of
the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction. “Black Scholes
Value” means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the “OV” function
on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A)
a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement
of the applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the lesser of 100%
and the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the
Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price
per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the
value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the highest VWAP during the five (5)
Trading Day period prior to the closing of the Fundamental Transaction and (D) a zero cost of borrow. The payment of the Black Scholes
Value will be made by wire transfer of immediately available funds (or such other consideration) within the later of (i) five Business
Days of the Holder’s election and (ii) five Business Days after the date of consummation of the Fundamental Transaction. The Company
shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”)
to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section 6 pursuant
to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (not to be unreasonably withheld,
conditioned or delayed) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this
Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent
to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise
of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such
shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction
and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of
protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably
satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall
be added to the term “Company” under this Warrant (so that from and after the occurrence or consummation of such Fundamental
Transaction, each and every provision of this Warrant referring to the “Company” shall refer instead to each of the Company
and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally
with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall
assume all of the obligations of the Company prior thereto under this Warrant with the same effect as if the Company and such Successor
Entity or Successor Entities, jointly and severally, had been named as the Company herein. As discussed herein, “VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Company reasonably acceptable to the Subscribers of a majority in interest of the Securities then outstanding,
the reasonable fees and out-of-pocket expenses of which shall be jointly paid by the Company and the Subscribers.

 

    14

     

    

 

7. Forfeiture
Upon Redemption of Note. Upon the Holder’s redemption of any Notes in accordance with Section 2(d)(i) of the Note, then a portion
of this Warrant shall be forfeited and cancelled in accordance with the following formula: For each $1,000 of Principal Amount (as such
term is defined in the Note) of Notes redeemed, Warrants to purchase 100% of the Warrant Shares issued per $1,000 of Principal Amount
shall be immediately forfeited and cancelled and the Holder shall not have any right to exercise, or any other rights, with respect to
such portion of the Warrants thereafter.

 

8. Holder
Not Deemed a Shareholder; Limitations on Liability. Except as otherwise specifically provided herein, prior to the issuance to the
Holder of the Warrant Shares to which the Holder is then entitled to receive upon the due exercise of this Warrant, the Holder shall not
be entitled to vote or receive dividends or be deemed the holder of shares of capital stock of the Company for any purpose, nor shall
anything contained in this Warrant be construed to confer upon the Holder, as such, any of the rights of a shareholder of the Company
or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of shares, reclassification
of shares, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise.
In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities
(upon exercise of this Warrant or otherwise) or as a shareholders of the Company, whether such liabilities are asserted by the Company
or by creditors of the Company.

 

9. Replacement
on Loss; Division and Combination.

 

(a) Replacement
of Warrant on Loss. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation
of this Warrant and upon delivery of an indemnity reasonably satisfactory to it (it being understood that a written indemnification agreement
or affidavit of loss of the Holder shall be a sufficient indemnity) and, in case of mutilation, upon surrender of such Warrant for cancellation
to the Company, the Company at its own expense shall execute and deliver to the Holder, in lieu hereof, a new Warrant of like tenor and
exercisable for an equivalent number of Warrant Shares as the Warrant so lost, stolen, mutilated or destroyed; provided, that, in the
case of mutilation, no indemnity shall be required if this Warrant in identifiable form is surrendered to the Company for cancellation.

 

    15

     

    

 

(b) Division
and Combination of Warrant. Subject to compliance with the applicable provisions of this Warrant as to any transfer or other
assignment which may be involved in such division or combination, this Warrant may be divided or, following any such division of
this Warrant, subsequently combined with other Warrants, upon the surrender of this Warrant or Warrants to the Company at its then
principal executive offices, together with a written notice specifying the names and denominations in which new Warrants are to be
issued, signed by the respective Holders or their agents or attorneys. Subject to compliance with the applicable provisions of this
Warrant as to any transfer or assignment which may be involved in such division or combination, the Company shall at its own expense
execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants so surrendered in accordance with such notice.
Such new Warrant or Warrants shall be of like tenor to the surrendered Warrant or Warrants and shall be exercisable in the aggregate
for an equivalent number of Warrant Shares as the Warrant or Warrants so surrendered in accordance with such notice.

 

10. Compliance
with the Securities Act; Market Stand-Off Agreement.

 

(a) Agreement
to Comply with the Securities Act; Legend. The Holder, by acceptance of this Warrant, agrees to comply in all respects with the provisions
of this Section 10 and the restrictive legend requirements set forth on the face of this Warrant and further agrees that such Holder shall
not offer, sell or otherwise dispose of this Warrant or any Warrant Shares to be issued upon exercise hereof except under circumstances
that will not result in a violation of the Securities Act. This Warrant and all Warrant Shares issued upon exercise of this Warrant (unless
registered under the Securities Act) shall be stamped or imprinted with a legend in substantially the following form:

 

“THIS WARRANT AND THE SECURITIES
ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED
OR ASSIGNED UNLESS (I) A REGISTRATION STATEMENT COVERING SUCH SECURITIES IS EFFECTIVE UNDER THE ACT AND IS QUALIFIED UNDER APPLICABLE
STATE AND FOREIGN LAW OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS UNDER THE ACT AND THE
QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND, IF THE CORPORATION REQUESTS, AN OPINION OF COUNSEL, WHICH COUNSEL
AND OPINION ARE SATISFACTORY TO THE COMPANY, THAT SUCH REQUIREMENTS HAVE BEEN SATISFIED AS DETERMINED BY THE CORPORATION.”

 

    16

     

    

 

(b) Representations
of the Holder. In connection with the issuance of this Warrant, the Holder specifically represents, as of the date hereof and as of
each date of exercise of this Warrant, to the Company by acceptance of this Warrant as follows:

 

(i) The Holder
is an “accredited investor” as defined in Rule 501(a) of Regulation D promulgated under the Securities Act. The Holder
is acquiring this Warrant and the Warrant Shares to be issued upon exercise hereof for investment for its own account and not with a
view towards, or for resale in connection with, the public sale or distribution of this Warrant or the Warrant Shares, except
pursuant to sales registered or exempted under the Securities Act.

 

(ii) The
Holder understands and acknowledges that this Warrant and the Warrant Shares to be issued upon exercise hereof are “restricted securities” under the federal securities laws inasmuch
as they are being acquired from the Company in a transaction not involving a public offering and that, under such laws and applicable
regulations, such securities may be resold without registration under the Securities Act only in certain limited circumstances. In addition,
the Holder represents that it is familiar with Rule 144 under the Securities Act, as presently in effect, and understands the resale limitations
imposed thereby and by the Securities Act.

 

(iii) The
Holder acknowledges that it can bear the economic and financial risk of its investment for an indefinite period, and has such knowledge
and experience in financial or business matters that it is capable of evaluating the merits and risks of the investment in the Warrant
and the Warrant Shares. The Holder has had an opportunity to ask questions and receive answers from the Company regarding the terms and
conditions of the offering of the Warrant and the business, properties, prospects and financial condition of the Company.

 

(c) The
Holder understands that no trading market or other market for the Warrant or the Warrant Shares exists and one may never exist. The Holder
acknowledges that the Company is relying on the representations and warranties of the Holder to be accurate so that the offer of the Warrant
and the Warrant Shares is exempt from registration under the Securities Act.

 

(d) Market
Stand-Off Agreement. The Holder hereby agrees that it is subject to that certain Lock-Up Agreement dated as of the Original Issue
Date.

 

    17

     

    

 

In order to enforce the foregoing covenant,
the Company may impose stop transfer instructions with respect to the Holder’s registrable securities of the Company (and the Company
shares or securities of every other person subject to the foregoing restriction) until the end of such period. The Holder agrees that
a legend reading substantially as follows will be placed on all certificates representing all of the Holder’s registrable securities
of the Company (and the Company shares or securities of every other person subject to the restriction contained in this Section 10(c)):

 

THE SECURITIES REPRESENTED BY THIS
CERTIFICATE ARE SUBJECT TO A LOCK-UP PERIOD AS SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE ORIGINAL HOLDER OF THESE SECURITIES,
A COPY OF WHICH MAY BE OBTAINED AT THE COMPANY’S PRINCIPAL OFFICE. SUCH LOCK-UP PERIOD IS BINDING ON TRANSFEREES OF THESE SECURITIES.

 

11. Warrant
Register. The Company shall keep and properly maintain at its principal executive offices books for the registration of the Warrant
and any transfers thereof. The Company may deem and treat the Person in whose name the Warrant is registered on such register as the Holder
thereof for all purposes, and the Company shall not be affected by any notice to the contrary, except any assignment, division, combination
or other transfer of the Warrant effected in accordance with the provisions of this Warrant.

 

12. Notices.
All notices, requests, consents, claims, demands, waivers and other communications hereunder shall be in writing and shall be deemed to
have been given: (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if sent by a nationally
recognized overnight courier (receipt requested); (c) on the date sent by facsimile or e-mail of a PDF document (with confirmation of
transmission) if sent during normal business hours of the recipient, and on the next Business Day if sent after normal business hours
of the recipient; or (d) on the third day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid.
Such communications must be sent to the respective parties at the addresses indicated below (or at such other address for a party as shall
be specified in a notice given in accordance with this Section 12).

 

	If to the Company:	Courtside Group, Inc.
	 	335 North Maple Drive, Suite 127
	 	
    Beverly Hills, CA 90210E-mail: kit@podcastone.com and

    tenia@liveone.com

	 	Attention: Kit Gray
	 	 
	with a copy to (which shall not constitute:	Foley Shechter Ablovatskiy LLP
	notice)	1180 Avenue of the Americas, 8th Floor
	 	New York, NY 10036
		E-mail: sablovatskiy@foleyshechter.com
		Attention: Sasha Ablovatskiy, Esq.
	 	 
	If to the Holder:	At Address set forth in Subscription Agreement

 

13. Cumulative
Remedies. Except to the extent expressly provided in Section 6 to the contrary, the rights and remedies provided in this Warrant are
cumulative and are not exclusive of, and are in addition to and not in substitution for, any other rights or remedies available at law,
in equity or otherwise.

 

14. Equitable
Relief. Each of the Company and the Holder acknowledges that a breach or threatened breach by such party of any of its obligations
under this Warrant would give rise to irreparable harm to the other party hereto for which monetary damages would not be an adequate remedy
and hereby agrees that in the event of a breach or a threatened breach by such party of any such obligations, the other party hereto shall,
in addition to any and all other rights and remedies that may be available to it in respect of such breach, be entitled to equitable relief,
including a restraining order, an injunction, specific performance and any other relief that may be available from a court of competent
jurisdiction.

 

    18

     

    

 

15. Entire
Agreement. This Warrant, together with the Subscription Agreement, the Note and the NDA (if applicable), constitutes the sole and
entire agreement of the parties to this Warrant with respect to the subject matter contained herein, and supersedes all prior and contemporaneous
understandings and agreements, both written and oral, with respect to such subject matter. In the event of any inconsistency between the
statements in the body of this Warrant and the Subscription Agreement, the statements in the body of this Warrant shall control.

 

16. Successor
and Assigns. This Warrant and the rights evidenced hereby shall be binding upon and shall inure to the benefit of the parties hereto
and the successors of the Company and the successors and permitted assigns of the Holder. Such successors and/or permitted assigns of
the Holder shall be deemed to be a Holder for all purposes hereunder.

 

17. No
Third-Party Beneficiaries. This Warrant is for the sole benefit of the Company and the Holder and their respective successors and,
in the case of the Holder, permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other Person
any legal or equitable right, benefit or remedy of any nature whatsoever, under or by reason of this Warrant.

 

18. Headings.
The headings in this Warrant are for reference only and shall not affect the interpretation of this Warrant.

 

19. Amendment
and Modification; Waiver. Except as otherwise provided herein, this Warrant may only be amended, modified or supplemented by with
the written consent of the Company and the Majority Noteholders (as defined in the Notes). No waiver by the Company or the Holder of any
of the provisions hereof shall be effective unless explicitly set forth in writing and signed by the party so waiving. No waiver by any
party shall operate or be construed as a waiver in respect of any failure, breach or default not expressly identified by such written
waiver, whether of a similar or different character, and whether occurring before or after that waiver. No failure to exercise, or delay
in exercising, any rights, remedy, power or privilege arising from this Warrant shall operate or be construed as a waiver thereof; nor
shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof
or the exercise of any other right, remedy, power or privilege.

 

20. Severability.
If any term or provision of this Warrant is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability
shall not affect any other term or provision of this Warrant or invalidate or render unenforceable such term or provision in any other
jurisdiction.

 

21. Governing
Law. This Warrant shall be governed by and construed in accordance with the internal laws of the State of New York without giving
effect to any choice or conflict of law provision or rule (whether of the State of New York or any other jurisdiction) that would cause
the application of laws of any jurisdiction other than those of the State of New York.

 

    19

     

    

 

22. Submission
to Jurisdiction. Any legal suit, action or proceeding arising out of or based upon this Warrant or the transactions contemplated hereby
may be instituted in the federal courts of the United States of America or the courts of the State of New York, and each party irrevocably
submits to the exclusive jurisdiction of such courts in any such suit, action or proceeding. Service of process, summons, notice or other
document by certified or registered mail to such party’s address set forth herein shall be effective service of process for any
suit, action or other proceeding brought in any such court. The parties irrevocably and unconditionally waive any objection to the laying
of venue of any suit, action or any proceeding in such courts and irrevocably waive and agree not to plead or claim in any such court
that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum.

 

23. Waiver
of Jury Trial. Each party acknowledges and agrees that any controversy which may arise under this Warrant is likely to involve complicated
and difficult issues and, therefore, each such party irrevocably and unconditionally waives any right it may have to a trial by jury in
respect of any legal action arising out of or relating to this Warrant or the transactions contemplated hereby.

 

24. Further
Assurances. From time to time, the parties will execute and deliver such additional documents and will provide such additional information
as may reasonably be required to carry out the terms of this Warrant and any agreements executed in connection herewith.

 

25. Counterparts.
This Warrant may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to
be one and the same agreement. A signed copy of this Warrant delivered by facsimile, e-mail or other means of electronic transmission
shall be deemed to have the same legal effect as delivery of an original signed copy of this Warrant.

 

[SIGNATURE PAGE FOLLOWS]

 

    20

     

    

 

IN WITNESS WHEREOF, the Company
has duly executed this Warrant on the Original Issue Date.

 

	 	Courtside Group, Inc.
	 	 	 
	 	By: 	 
	 	Name:  	Kit Gray
	 	Title:	President

 

[Signature Page to Courtside Group, Inc. Warrant
to Purchase Common Stock]

 

    21

     

    

 

EXHIBIT A

 

EXERCISE AGREEMENT

 

Courtside Group, Inc.

________________

________________

Attention: ______

 

1. Exercise
Notice. The undersigned holder hereby exercises the right to purchase __________________ of the shares of Common Stock (“Warrant
Shares”) of Courtside Group, Inc., a corporation organized under the laws of Delaware (the “Company”), evidenced
by the attached Warrant. Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.

 

2. Form
of Exercise Price. The Holder intends that payment of the Exercise Price shall be made as:

 

☐
 a “Cash Exercise” with respect to __________________ Warrant Shares; and/or

 

☐ a
“Cashless Exercise” with respect to __________________ Warrant Shares.

 

3. Payment
of Exercise Price. In the event that the holder has elected a Cash Exercise with respect to some or all of the Warrant Shares to be issued
pursuant hereto, the holder shall pay the Aggregate Exercise Price in the sum of $____________ to the Company in accordance with the terms
of the Warrant, which sum represents payment in full for the purchase price of the Warrant Shares being purchased, together with all applicable
transfer taxes, if any.

 

4. Please
issue a certificate or certificates representing said Warrant Shares in the name of the undersigned or in such other name as is specified
below:

 

	 	 
	 	(Name)
	 	 
	 	 
	 	 
	 	 
	 	(Address)

 

5. Representations
and Warranties. The undersigned hereby represents and warrants that the aforesaid Warrant Shares are being acquired for the account of
the undersigned for investment and not with a view to, or for resale, in connection with the distribution thereof, and that the undersigned
has no present intention of distributing or reselling such shares and all representations and warranties of the undersigned set forth
in Section 8 of the attached Warrant are true and correct as of the date hereof.

 

	 	 
	 	 (Signature)
	 	 
	 	 
	 	(Name)

 

	 	 	 
	(Date)	 	(Title)

 

 

    22

     

    

 

EXHIBIT B

 

FORM OF ASSIGNMENT

 

(To be signed only upon transfer of Warrant)

 

Courtside Group, Inc.

________________

________________

Attention: _______

 

FOR VALUE RECEIVED, the undersigned
hereby sells, assigns and transfers unto __________________ the right represented by the attached Warrant to purchase __________________
Common Stock of Courtside Group, Inc. to which the attached Warrant relates, and appoints ___________________ Attorney to transfer such
right on the books of Courtside Group, Inc., with full power of substitution in the premises.

 

Dated: ___________________

 

	 	 
	 	(Signature must conform in all respects to name of Holder as specified on the face of the Warrant)
	 	 
	 	Address:	 
	 	 	 
	 	 	 

 

Signed in the presence of:

 

_______________________________

 

 

 

23Exhibit 10.1

 

COURTSIDE GROUP, INC. 

(dba
podcastone)

SUBSCRIPTION AGREEMENT

(July 2022)

 

Courtside Group, Inc.

335 North Maple Drive, Suite 127

Beverly Hills, CA 90210

 

Ladies and Gentlemen:

 

The undersigned subscriber
or subscribers (hereinafter, the “Subscriber”) has received and carefully read the Courtside Group, Inc.’s (dba PodcastOne)
Subscription Booklet, dated July 2022, and supplements, if any, thereto and exhibits thereto (collectively, the “Subscription Booklet”),
including, without limitation, the form of Note (as defined below) and form of Warrant (as defined below), which describes the terms and
conditions by which an investor may participate and invest in Courtside Group, Inc., a company incorporated under the laws of Delaware
(the “Company”). Capitalized terms used and not defined herein shall have the same meanings as in the Subscription Booklet.

 

1.
Subscription.

 

(a) Subject
to the terms and conditions of this subscription agreement (the “Subscription Agreement”), the Subscriber hereby irrevocably
subscribes for and agrees to invest the amount indicated on the signature page hereof in the Company and hereby tenders this Subscription
Agreement, together with a check or wire transfer in such amount, for the number of units (the “Units”) set forth on the signature
page hereof at a purchase price of $100,000 per Unit. The minimum subscription is $100,000 per Subscriber but the Company, in their sole
discretion, may waive such minimum investment requirement from time to time. All subscription funds will be held in a non-interest bearing
escrow account in the Company’s name at Signature Bank, 261 Madison Avenue, New York, NY 10016 pending a closing, as follows:

 

	
    Name of Bank:

Bank Address:

    ABA Number:

    A/C Name:

    A/C Number:
	
    Signature Bank

    261 Madison Avenue, New York, NY 10016

    026013576

    Signature Bank as Escrow Agent for

    Courtside Group, Inc.

    1504848589

 

(b) Subject
to earlier termination by either the Company or Joseph Gunnar & Co., LLC (the “Placement Agent”), the Units will be offered
through July 4, 2022, which period may be extended by the Company and the Placement Agent, in their mutual discretion, to a date not later
than September 2, 2022 (such date, as applicable, the “Termination Date”). The Subscriber agrees that this subscription shall
be irrevocable and shall survive the death or disability of the Subscriber if either the Company or the Placement Agent rejects a subscription,
either in whole or in part, funds received pursuant hereto will be returned to the Subscriber, without interest accrued thereon or deduction
therefrom.

 

     

     

    

 

(c) Each
Unit consists of (i) an Original Issue Discount Convertible Promissory Note in the principal amount of $110,000 including an Original
Issue Discount (OID) of 10.0%, (each a “Note” and collectively the “Notes”) of the Company, and (ii) a five-and-one-half-year
warrant (each a “Warrant” and collectively the “Warrants”) to purchase a number of shares (each a “Warrant Share”
and collectively the “Warrant Shares”) of the Company’s common stock, par value $0.00001 per share (the “common
stock”), equal to the quotient obtained by dividing 100% of the principal amount of the Note by the quotient of (x) $60,000,000
(the “Valuation Cap”) divided by (y) the Fully Diluted Capitalization immediately prior to the Qualified Financing or the
Qualified Event, as applicable, at a per share exercise price equal to (A) if a Qualified Financing or the Qualified Event, as applicable
has occurred on or before the Maturity Date (as defined in the Notes), the lower of (i) the quotient of (x) the Valuation Cap divided
by (y) the Fully Diluted Capitalization immediately prior to the Qualified Financing or the Qualified Event, as applicable, and (ii) the
purchase price per share or other whole unit in the Qualified Financing or the Qualified Event, as applicable, or (B) if a Qualified Financing
or the Qualified Event, as applicable, has not occurred on or before the Maturity Date, the Voluntary Conversion Price (as defined in
the Notes). This subscription is submitted to you in accordance with and subject to the terms and conditions described in this Subscription
Agreement and the Subscription Booklet relating to the offering (the “Offering”) by the Company of a minimum of 80 Units ($8,800,000
(including the OID)) (“Minimum Amount”), and up to a maximum of 100 Units ($11,000,000 (including the OID)) (“Maximum Amount”).
The Units are being sold in the Offering (as defined below) as more fully described in the Subscription Booklet. This Subscription Agreement
is one in a series of similar subscription agreements (collectively, the “Subscription Agreements”) entered into pursuant to
the Offering. As used herein, “Fully Diluted Capitalization” means the number of outstanding shares of the Company’s common
stock, assuming conversion of all outstanding securities convertible into shares of the Company’s common stock and exercise of all
outstanding options and warrants to purchase shares of common stock or other outstanding securities convertible into shares of common
stock, but excluding, for this purpose, (A) the conversion of any Notes (whether or not such Notes have actually been converted), (B)
the exercise of any Warrants (whether or not such Warrants have actually been exercised), (C) the exercise of any warrants issued to the
Placement Agent or any other placement agent or underwriter in connection with securities offered pursuant to the Subscription Booklet
or in the Qualified Financing or the Qualified Event, as applicable), and (D) any securities issued in connection with the Qualified Financing
or the Qualified Event, as applicable (including, without limitation, pursuant to any equity incentive plans); provided that in the case
of a Qualified Financing or the Qualified Event, as applicable, “Fully Diluted Capitalization” also shall exclude the shares
of common stock that are reserved for issuance under the Company’s existing or future equity incentive plan(s), compensation plans or
any equity incentive plan(s) to be adopted in connection with the offering of the Notes or the Qualified Financing or the Qualified Event,
as applicable, as the case may be.

 

2. Acceptance
of Subscription. The Company may, in its discretion at any time prior to the Termination Date, hold an initial closing for gross
proceeds to the Company of $8,000,000 (“Initial Closing”), provided that LiveOne, Inc., the Company’s parent (“LiveOne”
or “Parent”), shall have agreed to purchase $3,000,000 in gross proceeds to the Company of Notes and Warrants at the Initial
Closing, and, at any time and from time to time after the Initial Closing, may hold subsequent closings (each such closing, including
the Initial Closing, a “Closing,” and the final such Closing, the “Final Closing”), in each case, with respect
to any Units for which subscriptions have been accepted prior to such date. The Subscriber acknowledges and agrees that the Company, in
its sole discretion, has the right to accept or reject this subscription, in whole or in part, for any reason, and that this subscription
shall be deemed to be accepted by the Company only when it is signed by an authorized signatory on its behalf and the Subscriber’s
funds are received by the Company. The Subscriber agrees that subscriptions need not be accepted in the order they are received by the
Company. Upon rejection of this Subscription Agreement for any reason, including but not limited to if the Initial Closing does not occur
prior to the Termination Date or the aggregate subscription amount owed with respect to the Units purchased by the Subscriber pursuant
hereto (the “Subscription Amount”) is received after the Final Closing, all funds received with this Subscription Agreement
will be returned to the Subscriber without deduction for any fee, commission or expense and without interest with respect to any money
received, and this Subscription Agreement shall be deemed to be null and void and of no further force or effect. If this subscription
is rejected in part, the funds for the rejected portion of this subscription will be returned without interest or offset, and this Subscription
Agreement will continue in full force and effect to the extent this subscription was accepted.

 

    2

     

    

 

3. Representations,
Warranties and Covenants of the Subscriber. The Subscriber hereby represents and warrants to and covenants with the Company as
follows:

 

(a) The
Subscriber is an (i) “accredited investor” as such term is defined in Rule 501 of Regulation D promulgated under the Securities
Act of 1933, as amended (the “Securities Act”), and (ii) Confidential Subscriber Questionnaire (Entities) (collectively each
a “Confidential Subscriber Questionnaire”), as annexed hereto as Items F and FF, is complete, accurate and true
in all respects;

 

(b) Prior
to executing this Subscription Agreement, the Subscriber acknowledges that he (i) has received, read and is familiar with the Subscription
Booklet and recognizes that the Company has a limited operating history and that an investment in the Company involves a high degree of
risk and (ii) has carefully read and considered the matters set forth under the caption “Risk Factors” in the Subscription Booklet,
and, in particular, acknowledges that the Company engages in a highly competitive business, is a development stage company with no significant
operating history to date and has limited assets;

 

(c) The
Subscriber has been advised that there will be no market for the investment made in the Company, that such market may never develop and
it may not be possible to readily liquidate this investment, if at all. The Subscriber’s overall commitment to investments which are not
readily marketable is not disproportionate to his net worth; his investment in the Company will not cause such overall commitment to become
excessive; and he can afford to bear the loss of his entire investment in the Company;

 

(d) The
Subscriber has adequate means of providing for his current needs and personal contingencies and has no need for liquidity in his investment
in the securities comprising the Units for an indefinite period of time;

 

(e) The
Subscriber satisfies any special suitability or other applicable requirements of his state of residence and/or the state in which the
transaction by which the Units are purchased occurs;

 

(f) The
Subscriber has such knowledge and experience in financial, tax and business matters that he is capable of evaluating the merits and risks
of an investment in the Company and to make an informed investment decision with respect thereto, or the Subscriber has employed the services
of an investment advisor, attorney or accountant to read all of the documents furnished or made available by the Company both to him and
all other prospective investors in the Units and to evaluate the merits and risks of such an investment on the Subscriber’s behalf;

 

(g) The
Subscriber confirms that the Company has made available to Subscriber the opportunity to ask questions of, and receive answers from, a
person or persons acting on behalf of the Company concerning the Offering of the Units, the Company and the Company’s business, as described
in the Subscription Booklet, and otherwise to obtain any additional information, to the extent that the Company possess such information
or could acquire it without unreasonable effort or expense, necessary to verify the accuracy of the information contained in the Subscription
Booklet. In considering its investment in the Company, the Subscriber has not relied upon any representations made by, or other information
(whether oral or written) furnished by or on behalf of, the Company, LiveOne, the Placement Agent, or any director, officer, stockholder,
partner, employee, agent, member, or counsel, or any representative or affiliate of any of the foregoing, other than as expressly set
forth in the Subscription Booklet and this Subscription Agreement;

 

    3

     

    

 

(h) If
the Subscriber is an entity: (i) such entity was not formed for the specific purpose of acquiring the Units, (ii) such entity is duly
organized, validly existing and in good standing under the laws of the state of its organization, (iii) its decision to invest in the
Company was made in a centralized fashion (e.g. by a board of directors, general partner, manager, trustee, investment committee or similar
governing or managing body); (iv) it is not managed to facilitate the investment decisions of its beneficial owners regarding investments
(including an investment in the Company); and (vi) its shareholders, partners, members or beneficiaries, as applicable, did not and will
not (x) contribute additional capital for the purpose of acquiring the Units (y) have any discretion to determine whether or how much
of the Subscriber’s assets are being invested in any investment made by the Subscriber (including the Subscriber’s investment in the Company),
or (z) have the ability to individually elect whether or to what extent such shareholder, partner, member or beneficiary, as applicable,
will participate in the Subscriber’s investment in the Company;

 

(i) The
Subscriber hereby acknowledges that the Subscriber has been advised that this offering has not been registered with, or reviewed by, the
U.S. Securities and Exchange Commission (the “SEC”) because this offering is intended to be a non-public offering pursuant to
Section 4(a)(2) of the Securities Act and Regulation D as promulgated thereunder. The Subscriber represents that the Subscriber’s Units
are being purchased for the Subscriber’s own account, for investment purposes only and not with a view for distribution or resale to others.
The Subscriber agrees that the Subscriber will not sell or otherwise transfer the securities comprising the Units or the Shares issuable
upon conversion of the Notes and exercise of the Warrants (collectively, the “Note and Warrant Shares”) unless they are registered
under the Securities Act or unless in the opinion of counsel, which counsel and opinion are satisfactory to the Company, an exemption
from such registration is available. The Subscriber understands that the securities comprising the Units and the Note and Warrant Shares
have not been registered under the Securities Act by reason of a claimed exemption under the provisions of the Securities Act which depends,
in part, upon the Subscriber’s investment intention and the Subscriber’s representations, warranties and agreements contained herein.
In this connection, the Subscriber understands that it is the position of the SEC that the statutory basis for such exemption would not
be present if the Subscriber’s representation merely meant that the Subscriber’s present intention was to hold such Units for a short
period, such as the capital gains period of tax statutes, for a deferred sale or for any other fixed period. The Subscriber realizes that
the SEC might regard a purchase with an intent inconsistent with the Subscriber’s representation to the Company, and a sale or disposition
thereof, as a deferred sale to which the exemption is not available;

 

(j) The
Subscriber understands that neither the SEC nor the securities administrator of any state has made any finding or determination relating
to the fairness of this investment and that neither the SEC nor the securities administrator of any state has recommended or endorsed,
or will recommend or endorse, the offering of the Units, nor have any of them reviewed or passed upon the accuracy or adequacy of the
Subscription Booklet;

 

(k) The
execution, delivery and performance by the Subscriber of the Subscription Agreement are within the powers of the Subscriber, have been
duly authorized and will not constitute or result in a breach or default under, or conflict with, any order, ruling or regulation of any
court or other tribunal or of any governmental commission or agency, or any agreement or other undertaking, to which the Subscriber is
a party or by which the Subscriber is bound; and, if the Subscriber is not an individual, will not violate any provision of the charter
documents, by-laws, indenture of trust, operating agreement or partnership agreement, as applicable, of the Subscriber. The signatures
on the Subscription Agreement are genuine; and the signatory, if the Subscriber is an individual, has legal competence and capacity to
execute the same, or, if the Subscriber is not an individual, the signatory has been duly authorized to execute the same; and the Subscription
Agreement constitutes the legal, valid and binding obligations of the Subscriber, enforceable in accordance with its terms;

 

    4

     

    

 

(l) The
Subscriber is unaware of, is in no way relying on, and did not become aware of the Offering of the Units through or as a result of, any
form of general solicitation or general advertising including, without limitation, any article, notice, advertisement or other communication
published in any newspaper, magazine or similar media or broadcast over television, radio or the Internet (including, without limitation,
internet “blogs,” bulletin boards, discussion groups and social networking sites) in connection with the Offering and sale of
the Units and is not subscribing for the Units and did not become aware of the Offering of the Units through or as a result of any seminar
or meeting to which the Subscriber was invited by, or any solicitation of a subscription by, a person not previously known to the Subscriber
in connection with investments in securities generally.

 

(m) The
Subscriber has relied solely upon the advice of his own tax and legal advisors with respect to the tax and other legal aspects of this
investment;

 

(n) The
Subscriber understands that the Company will review this Subscription Agreement and the Subscriber’s Confidential Subscriber Questionnaire
and the Company is hereby given authority by the Subscriber to call the Subscriber’s bank or place of employment or otherwise investigate
or review the financial standing of the Subscriber; and it is further agreed that the Company reserves the unrestricted right to reject
or limit any subscription and to terminate the offer at any time;

 

(o) The
Subscriber understands that by reason of the Company’s obligation to pay certain fees and expenses of the Offering, as described in the
Subscription Booklet, not all of the gross proceeds of the Offering will be available for use by the Company;

 

(p) The
Subscriber is not (i) a retirement plan subject to the Employee Retirement Income Security Act of 1974, as amended (“ERISA”)
or Section 4975 of the Internal Revenue Code of 1986, as amended, another plan that is not subject to ERISA or any participant and beneficiary
of any of the foregoing, (ii) an individual retirement account or its beneficial owner, or (iii) a fiduciary of any of the foregoing plans
or individual retirement accounts;

 

(q) The
Subscriber is not aware that any person, and has been advised that no person (other than the Placement Agent), will receive from the Company
any compensation as a broker, finder, adviser or in any other capacity in connection with the purchase of Units and the Subscriber has
taken no action that would give rise to any claim by any person for brokerage commissions, finders’ fees or the like relating to this
Subscription Agreement or the transactions contemplated hereby (other than commissions to be paid by the Company to the Placement Agent
or as otherwise described in the Subscription Booklet);

 

(r) By
executing and delivering this Subscription Agreement, the Subscriber covenants to the Company that, except with the prior written permission
of the Company, the Subscriber shall at all times keep confidential and not divulge, furnish or make accessible to anyone any information
contained in the Subscription Booklet, including the exhibits and attachments thereto. The provisions of this Paragraph 3(r) shall be
in addition to, and not in substitution for, the provisions of any separate nondisclosure agreement executed by the parties hereto with
respect to the transactions contemplated hereby;

 

    5

     

    

 

(s) The
Subscriber acknowledges that Signature Bank is acting solely as Escrow Agent in connection with the offering of the Units and makes no
recommendation with respect thereto. Signature Bank has made no investigation regarding the Offering, the Company, LiveOne or any other
person or entity involved in the Offering;

 

(t) The
Subscriber acknowledges that any estimates or forward-looking statements or projections included in the Subscription Booklet were prepared
by the Company in good faith but that the attainment of any such projections, estimates or forward-looking statements cannot be guaranteed
by the Company or LiveOne and should not be relied upon;

 

(u) The
Subscriber’s substantive relationship with the Placement Agent or subagent through which the Subscriber is subscribing for Units predates
the Placement Agent’s or such subagent’s contact with the Subscriber regarding an investment in Units;

 

(v) SUBSCRIBER
ACKNOWLEDGES THAT THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT, OR THE SECURITIES LAWS OF ANY STATES
AND ARE BEING OFFERED AND SOLD IN RELIANCE UPON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF SAID ACT AND SUCH LAWS. THE SECURITIES
ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER SAID ACT AND
SUCH LAWS PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. THE SECURITIES HAVE NOT BEEN APPROVED, DISAPPROVED OR RECOMMENDED BY THE SECURITIES
AND EXCHANGE COMMISSION, ANY STATE SECURITIES COMMISSION OR ANY OTHER REGULATORY AUTHORITY, NOR HAVE ANY OF THE FOREGOING AUTHORITIES
PASSED UPON OR ENDORSED THE MERITS OF THIS OFFERING OR THE ACCURACY OR ADEQUACY OF THE SUBSCRIPTION BOOKLET. ANY REPRESENTATION TO THE
CONTRARY IS UNLAWFUL;

 

(w) The
Subscriber should check the Office of Foreign Assets Control (“OFAC”) website at <http://www.treas.gov/ofac> before making
the following representations. The Subscriber represents that the amounts invested by it in the Company were not and are not directly
or indirectly derived from activities that contravene U.S. Federal, state or international laws and regulations, including anti-money
laundering laws and regulations. U.S. Federal regulations and Executive Orders administered by OFAC prohibit, among other things, the
engagement in transactions with, and the provision of services to, certain foreign countries, territories, entities and individuals.1
The lists of OFAC prohibited countries, territories, persons and entities can be found on the OFAC website at <http://www.treas.gov/ofac>.
In addition, the programs administered by OFAC (the “OFAC Programs”) prohibit dealing with individuals or entities in certain
countries regardless of whether such individuals or entities appear on the OFAC lists;

 

(x) The
Subscriber represents and warrants that, to the best of its knowledge, none of: (1) the Subscriber; (2) any person controlling or controlled
by the Subscriber; (3) if the Subscriber is a privately-held entity, any person having a beneficial interest in the Subscriber; or (4)
any person for whom the Subscriber is acting as agent or nominee in connection with this investment is a country, territory, individual
or entity named on an OFAC list, or a person or entity prohibited under the OFAC Programs. Please be advised that the Company may not
accept any amounts from a prospective investor if such investor cannot make the representation set forth in the preceding paragraph. The
Subscriber agrees to promptly notify the Company should the Subscriber become aware of any change in the information set forth in these
representations. The Subscriber is advised that, by law, the Company may be obligated to “freeze the account” of the Subscriber,
either by prohibiting additional subscriptions from the Subscriber, declining any redemption requests and/or segregating the assets in
the account in compliance with governmental regulations, and the Company may also be required to report such action and to disclose the
Subscriber’s identity to OFAC. The Subscriber further acknowledges that the Company may, by written notice to the Subscriber, suspend
the redemption rights (if any) of the Subscriber if the Company reasonably deems it necessary to do so to comply with anti-money laundering
regulations applicable to the Company or any of the Company’s other service providers. These individuals include specially designated
nationals, specially designated narcotics traffickers and other parties subject to OFAC sanctions and embargo programs;

 

 

1
These individuals include specially designated nationals, specially designated narcotics traffickers and other parties subject
to OFAC sanctions and embargo programs.

 

    6

     

    

 

(y) The
Subscriber represents and warrants that, to the best of its knowledge, none of: (1) the Subscriber; (2) any person controlling or
controlled by the Subscriber; (3) if the Subscriber is a privately-held entity, any person having a beneficial interest in the
Subscriber; or (4) any person for whom the Subscriber is acting as agent or nominee in connection with this investment is a senior
foreign political figure,2 or any
immediate family member 3 or close
associate 4 of a senior foreign
political figure, as such terms are defined in the footnotes below;

 

(z) If
the Subscriber is affiliated with a non-U.S. banking institution (a “Foreign Bank”), or if the Subscriber receives deposits
from, makes payments on behalf of, or handles other financial transactions related to a Foreign Bank, the Subscriber represents and warrants
to the Company that: (1) the Foreign Bank has a fixed address, other than solely an electronic address, in a country in which the Foreign
Bank is authorized to conduct banking activities; (2) the Foreign Bank maintains operating records related to its banking activities;
(3) the Foreign Bank is subject to inspection by the banking authority that licensed the Foreign Bank to conduct banking activities; and
(4) the Foreign Bank does not provide banking services to any other Foreign Bank that does not have a physical presence in any country
and that is not a regulated affiliate; and

 

(aa) (For Residents
of All States) The Subscriber acknowledges that the Units, Notes and the Warrants have not been recommended by any federal or state securities
commission or regulatory authority. In making an investment decision investors must rely on their own examination of the Company and the
terms of the offering, including the merits and risks involved. Furthermore, the foregoing authorities have not confirmed the accuracy
or determined the adequacy of this document. Any representation to the contrary is a criminal offense. The Units, the Notes, the Warrants
and the Note and Warrant Shares issuable upon exercise of the Notes and Warrants, respectively, are subject to restrictions on transferability
and resale and may not be transferred or resold except as permitted under the Securities Act, and the applicable state securities laws,
pursuant to registration or exemption therefrom. Subscribers should be aware that they will be required to bear the financial risks of
this investment for an indefinite period of time, including a complete loss of capital.

 

(bb) The Subscriber
agrees to enter into a lock-up agreement with the Company pursuant to which the Subscriber will not offer, sell, contract to sell, hypothecate,
pledge or otherwise dispose of shares of the Company’s common stock or common stock equivalent for a period of ninety (90) days
from the closing of the Qualified Financing or Qualified Event, as applicable (the “Lock-Up Period”), subject to certain exceptions
outlined in the lock-up agreement.

 

The foregoing representations
and warranties are true and accurate as of the date hereof, shall be true and accurate as of the date of (i) delivery of this Subscription
Agreement and accompanying documents to the Company and shall survive such delivery, (ii) the date of any conversion of the Note, and
(iii) the date of any exercise of the Warrant. If, in any respect, those representations and warranties shall not be true and accurate
prior to delivery of the payment of the purchase price of the Units or the date of any conversion of the Note or the date of any exercise
of the Warrant, the undersigned shall immediately give written notice to the Company specifying which representations and warranties are
not true and accurate and the reason therefor. In addition, the Subscriber agrees to notify the Company immediately in writing if the
Subscriber ceases to be an “accredited investor” within the meaning of Rule 501(a) of Regulation D under the Securities Act.
Until the Subscriber provides a notice described in the preceding two sentences, the Company may rely on the representations, warranties,
covenants and agreements contained herein in connection with any matter related to the Company. Without limiting the generality of the
preceding sentence, the Company may assume that all such representations and warranties are correct in all respects as of the date hereof
and the date of any conversion of the Note or the date of any exercise of the Warrant and may rely on such representations and warranties
in determining whether (i) the Subscriber is suitable as a purchaser of Units, (ii) Units may be sold to the Subscriber or any other Subscriber
without first registering the Units under the Securities Act or any other applicable securities laws, (iii) the conditions to the acceptance
of subscriptions for Units have been satisfied, (iv) the Subscriber meets the eligibility standards set by the Company and (v) whether
the Note and Warrant Shares can be issued to the Subscriber.

 

 

2
A “senior foreign political figure” is defined as a current or former senior official in the executive, legislative,
administrative, military or judicial branches of a foreign government (whether elected or not), a senior official of a major foreign
political party, or a senior executive of a foreign government-owned commercial enterprise. In addition, a “senior foreign political
figure” includes any corporation, business or other entity that has been formed by, or for the benefit of, a senior foreign political
figure.

 

3
“Immediate family” of a senior foreign political figure typically includes the figure’s parents, siblings, spouse,
children and a spouses’ parents and siblings.

 

4
A “close associate” of a senior foreign political figure is a person who is widely and publicly known (or is actually
known by the relevant covered financial institution) to maintain an unusually close relationship with the senior foreign political figure,
and includes a person who is in a position to conduct substantial domestic and international financial transactions on behalf of the
senior foreign political figure.

 

    7

     

    

 

4. Representations,
Warranties and Covenants of the Company. The Company hereby represents and warrants to and covenants with the Subscriber as follows:

 

(a) The
Units, the Notes, and the Warrants have been duly authorized and reserved for issuance and, when issued and paid for in accordance with
this Subscription Agreement upon the closing of this Subscription Agreement, will be duly and validly issued, fully paid and non-assessable,
will have been issued in compliance with all applicable federal, state, and U.S. securities laws, and will not have been issued in violation
of or subject to any preemptive or similar right that does or will entitle any Person (as defined below) to acquire any Relevant Security
from the Company or any Subsidiary upon issuance or sale of the Securities in this offering. Except as part of or in connection with the
Offering or the IPO (as defined below), pursuant to the Spin-Out or pursuant to any existing of future equity incentive plan or other
compensation plan of the Company, neither the Company nor any Subsidiary has outstanding warrants, options to purchase, or any preemptive
rights or other rights to subscribe for or to purchase, or any contracts or commitments to issue or sell, any Relevant Security. As used
herein, the term “Person” means any foreign or domestic individual, corporation, trust, partnership, joint venture, limited
liability company or other entity. As used herein, the term “Relevant Security” means any Shares or other security of the
Company that is convertible into, or exercisable or exchangeable for Shares or equity securities of the Company, or that holds the right
to acquire any Shares or equity securities of the Company or any other such Relevant Security. The “Spin-Out” means one or
more transactions in which the Company shall issue shares to LiveOne’s stockholders in connection with the Company’s contemplated
public offering (the “IPO”).

 

(b) The
Shares underlying the Notes (the “Conversion Shares”) have been duly authorized for issuance, have been validly reserved for
future issuance and will, upon conversion of the Notes, be duly and validly issued, fully paid and non-assessable and have been issued
in compliance with all federal and state securities laws, and will not have been issued in violation of or subject to preemptive or similar
rights to subscribe for or purchase securities of the Company. The issuance of such securities is not subject to any statutory preemptive
rights and is not and will not be subject to any preemptive rights under the Company’s certificate of incorporation or bylaws as
in effect at the time of issuance, rights of first refusal or other similar rights of any security holder of the Company

 

(c) The
Warrant Shares (together with the Units, the Notes, the Warrants, and the Conversion Shares, the “Securities”) have been duly
authorized for issuance, have been validly reserved for future issuance and will, upon exercise of the Warrants and payment of the exercise
price thereof, be duly and validly issued, fully paid and non-assessable and have been issued in compliance with all federal and state
securities laws, and will not have been issued in violation of or subject to preemptive or similar rights to subscribe for or purchase
securities of the Company. The issuance of such securities is not subject to any statutory preemptive rights and is not and will not be
subject to any preemptive rights under the Company’s certificate of incorporation or bylaws as in effect at the time of issuance,
rights of first refusal or other similar rights of any security holder of the Company.

 

    8

     

    

 

(d) The
Company holds no ownership or other interest, nominal or beneficial, direct or indirect, in any corporation, partnership, joint venture
or other business entity other than the entities itemized on Schedule 4(d) hereto or as disclosed in the SEC Reports (as defined below)
(the “Subsidiaries” and each a “Subsidiary”). All of the issued and outstanding shares of capital stock of the
Subsidiaries have been duly and validly authorized and issued and are fully paid and non-assessable and are owned directly by the Company.

 

(e) Each
of the Company and the Subsidiaries have been duly incorporated, formed or organized, and validly exists as a corporation, partnership
or limited liability company in good standing under the laws of its jurisdiction of incorporation, formation or organization. Each of
the Company and the Subsidiaries have all requisite power and authority to carry on its business as it is currently being conducted, and
to own, lease and operate its respective properties. Each of the Company and the Subsidiaries is duly qualified to do business and is
in good standing as a foreign corporation, partnership or limited liability company in each jurisdiction in which the character or location
of its properties (owned, leased or licensed) or the nature or conduct of its business makes such qualification necessary, except, in
each case, for those failures to be so qualified or in good standing which (individually and in the aggregate) would not reasonably be
expected to have a material adverse effect on clauses (i) through (iii) below, or any event, circumstance, change or effect that, individually
or in the aggregate with all other events, circumstances, changes and effects, is or is reasonably likely to be materially adverse to:
(i) the business, condition (financial or otherwise), assets, liabilities, results of operations, shareholders’ equity, properties
or prospects of the Company and the Subsidiaries, taken as a whole; (ii) the offering or consummation of any of the other transactions
contemplated by this Subscription Agreement, or (iii) the ability of the Company to consummate the transactions contemplated by this Agreement
and to perform its obligations under this Subscription Agreement, the Notes, the Warrant, or the Other Transaction Documents (as defined
below) (any such effect being a “Material Adverse Effect”).

 

(f) Except
as set forth in Schedule 4(f), there is no judicial, regulatory, arbitral or other legal or governmental proceeding or other litigation
or arbitration, domestic or foreign, pending to which the Company, any Subsidiary, or any of its officers or directors is a party or of
which any property, operations or assets of the Company or any Subsidiary is the subject which, individually or in the aggregate, if determined
adversely to the Company or any Subsidiary, would reasonably be expected to have a Material Adverse Effect, and to the Company’s
knowledge, no such proceeding, litigation or arbitration is threatened or contemplated. Each of the Company and the Subsidiaries is in
compliance with all applicable laws, rules, regulations, ordinances, directives, judgments, decrees and orders, foreign and domestic,
except for any non-compliance the consequences of which would not have or reasonably be expected to have a Material Adverse Effect. Neither
the Company, nor any of its Affiliates (within the meaning of Rule 144 under the Securities Act) (“Affiliates”) has received
any notice or other information from any regulatory or other legal or governmental agency which could reasonably be expected to result
in any material default or potential decertification by the Company, or any of its Affiliates. Except as described in the Subscription
Booklet or in the financial statements of the Company attached thereto, the Company has not received any notice of any violation of, or
noncompliance with, any federal, state, local or foreign laws, ordinances, regulations and orders (including, without limitation, those
relating to environmental protection, occupational safety and health, securities laws, equal employment opportunity, consumer protection,
credit reporting, “truth-in-lending”, and warranties and trade practices) applicable to its business, the violation of, or noncompliance
with, which would have or would reasonably be expected to have a Material Adverse Effect, and the Company knows of no facts or set of
circumstances which could give rise to such a notice, which would have or would reasonably be expected to have a Material Adverse Effect.

 

    9

     

    

 

(g) The
Company is not a party or subject to the provisions of any material order, writ, injunction, judgment or decree of any governmental authority
that has not been satisfied in full, otherwise discharged or which, if determined adversely, could reasonably be expected to have a Material
Adverse Effect.

 

(h) Except
as disclosed in Schedule 4(h), neither the Company nor the Subsidiaries: (i) is in violation of its certificate or articles of incorporation,
memorandum and articles of association, by-laws, certificate of formation, limited liability company agreement, joint venture agreement,
partnership agreement or other organizational documents, (ii) is in default under, and no event has occurred which, with notice or lapse
of time or both, would constitute a default under or result in the creation or imposition of any lien, charge, mortgage, pledge, security
interest, claim, equity, trust or other encumbrance, preferential arrangement, defect or restriction of any kind whatsoever (any “Lien”)
upon any of its property or assets pursuant to, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument
to which it is a party or by which it is bound or to which any of its property or assets is subject, or (iii) is in violation in any respect
of any law, rule, regulation, ordinance, directive, judgment, decree or order of any judicial, regulatory or other legal or governmental
agency or body, foreign or domestic, except (solely with regard to (ii) and (iii) above) for such violations or defaults which (individually
or in the aggregate) would not reasonably be expected to have a Material Adverse Effect.

 

(i) The
Company has full right, power and authority to execute and deliver this Subscription Agreement, the Notes, the Warrants, and all other
agreements, documents, certificates and instruments required to be delivered pursuant to this Subscription Agreement (collectively, the
“Other Transaction Documents”). The Company has duly and validly authorized this Subscription Agreement, the Notes, the Warrants,
the Other Transaction Documents, and each of the transactions contemplated thereby. This Subscription Agreement and the Other Transaction
Documents have been duly and validly executed and delivered by the Company and constitute the legal, valid and binding obligations of
the Company and are enforceable against the Company in accordance with their respective terms, except as enforceability may be limited
by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally and except
as enforceability may be subject to general principles of equity (regardless of whether such enforceability is considered in a proceeding
in equity or at law).

 

(j) When
issued, the Note will constitute valid and binding obligations of the Company to issue and sell, upon conversion thereof, the number and
type of securities of the Company called for thereby in accordance with the terms thereof and such Notes are enforceable against the Company
in accordance with their respective terms, except: (i) as such enforceability may be limited by bankruptcy, insolvency, reorganization
or similar laws affecting creditors’ rights generally; (ii) as enforceability of any indemnification or contribution provision may
be limited under federal and state securities laws; and (iii) that the remedy of specific performance and injunctive and other forms of
equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may
be brought.

 

    10

     

    

 

(k) When
issued, the Warrants will constitute valid and binding obligations of the Company to issue and sell, upon exercise thereof and payment
of the respective exercise prices therefor, the number and type of securities of the Company called for thereby in accordance with the
terms thereof and such Warrants are enforceable against the Company in accordance with their respective terms, except: (i) as such enforceability
may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights generally; (ii) as enforceability
of any indemnification or contribution provision may be limited under federal and state securities laws; and (iii) that the remedy of
specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion
of the court before which any proceeding therefor may be brought.

 

(l) Except
as set forth on Schedule 4(l) (the “Required Consents”), the execution, delivery, and performance of this Subscription Agreement,
the Notes, the Warrants, and the Other Transaction Documents, and consummation of the transactions contemplated by this Subscription Agreement,
including the issuance, sale and delivery of the Securities to be issued, sold and delivered hereunder, do not and will not: (i) conflict
with, require Consent under or result in a breach of any of the terms and provisions of, or constitute a default (or an event which with
notice or lapse of time, or both, would constitute a default) under, or result in the creation or imposition of any Lien upon any property
or assets of the Company or any Subsidiary pursuant to, any indenture, mortgage, deed of trust, loan agreement or other agreement, instrument,
franchise, license or permit to which the Company or any Subsidiary is a party or by which the Company or any Subsidiary or their respective
properties, operations or assets may be bound, or (ii) violate or conflict with any provision of the certificate or articles of incorporation,
by-laws, certificate of formation, limited liability company agreement, partnership agreement or other organizational documents of the
Company or any Subsidiary, or (iii) violate or conflict with any law, rule, regulation, ordinance, directive, judgment, decree or order
of any legal or require Consent from, any governmental agency or body, domestic or foreign, or (iv) trigger a reset or repricing of any
outstanding securities of the Company, except in the case of subsections (i) and (iii) for any default, conflict or violation that would
not have or reasonably be expected to have a Material Adverse Effect, except for such Consents as may be required under federal or state
securities or blue sky laws or the by-laws, each of which has been obtained and is in full force and effect or will be obtained and will
be in full force and effect. The Company has obtained the Required Consents, which are in full force and effect as of the date of each
closing of the Offering.

 

(m) Each
of the Company and the Subsidiaries has all consents, approvals, authorizations, orders, registrations, qualifications, licenses, filings
and permits of, with and from all judicial, regulatory and other legal or governmental agencies and bodies and all third parties, foreign
and domestic (collectively, the “Consents”), to own, lease and operate its properties and conduct its business as it is now
being conducted or is contemplated to be conducted, and each such Consent is valid and in full force and effect, except where, either
individually or in the aggregate, the absence or ineffectiveness of such Consent would not be expected to have a Material Adverse Effect.
Neither the Company nor any Subsidiary has received notice of any investigation or proceedings which results in or, if decided adversely
to the Company or any Subsidiary, could reasonably be expected to result in, the revocation of, or imposition of a materially burdensome
restriction on, any Consent, except where the revocation of, or imposition of a materially burdensome restriction on, any Consent would
not be expected to have a Material Adverse Effect. No Consent contains a materially burdensome restriction, except where the failure to
obtain such Consent would not be expected to have a Material Adverse Effect.

 

    11

     

    

 

(n) Except
as set forth in the reports, schedules, forms, statements and other documents filed by LiveOne with the SEC (the “SEC Reports”),
the Company maintains a system of internal accounting controls designed to provide reasonable assurances that (A) transactions are
executed in accordance with management’s general or specific authorization; (B) transactions are recorded as necessary to permit
preparation of financial statements in conformity with United States generally accepted accounting principles (“GAAP”) and
to maintain accountability for assets; (C) access to assets is permitted only in accordance with management’s general or specific
authorization; and (D) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate
action is taken with respect to any differences. Except as set forth in the SEC Reports, since the date of the Company’s incorporation,
there has been no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably
likely to materially affect, the Company’s internal control over financial reporting.

 

(o) Except
as set forth in the SEC Reports, the Company’s board of directors of has not been informed, nor is any executive officer or director
of the Company aware, of: (i) any significant deficiencies or material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report
financial information; or (ii) any fraud, whether or not material, that involves management or other employees who have a significant
role in the Company’s internal control over financial reporting.

 

(p) Neither
the Company nor any of its Affiliates has, prior to the date hereof, directly or indirectly, made any offer or sale of any securities
which are required to be “integrated” pursuant to the Securities Act or the rules and regulations of the SEC with the offer
and sale of the Securities pursuant to this Subscription Agreement. Neither the Company nor any of its Affiliates has sold or issued any
Relevant Security during the six (6)-month period preceding the date hereof, including but not limited to any sales pursuant to Rule 144A
or Regulation D or Regulation S under the Securities Act, other than Shares issued pursuant to employee benefit plans, qualified stock
option plans or employee compensation plans or pursuant to outstanding options, rights or warrants.

 

(q) No
director or officer of the Company is subject to any non-competition agreement or non-solicitation agreement with any employer or prior
employer other than LiveOne which could materially affect such person’s ability to be and act in such person’s respective
capacity of the Company.

 

    12

     

    

 

(r) Except
in connection with this Offering or the Placement Agent, no holder of any securities of the Company or any Relevant Security has any rights
to require the Company to register any such securities under the Securities Act as part or on account of, or otherwise in connection with,
the offer and sale of the Securities contemplated hereby, and any such rights so disclosed have either been fully complied with by the
Company or effectively waived by the holders thereof, and any such waivers remain in full force and effect.

 

(s) The
Company is not and, at all times up to and including consummation of the transactions contemplated by this Subscription Agreement, and
after giving effect to application of the net proceeds of this offering, will not be, subject to registration as an “investment
company” under the Investment Company Act of 1940, as amended, and is not and will not be an entity “controlled” by
an “investment company” within the meaning of such act. Neither the Company nor any of the Subsidiaries is, and, after giving
effect to this offering and the application of the proceeds thereof, neither of them will be, a “controlled foreign corporation”
as defined by the U.S. Internal Revenue Code of 1986, as amended.

 

(t) LiveOne
has filed all SEC Reports required to be filed by the Company under the Securities Act and the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof
(or such shorter period as LiveOne was required by law or regulation to file such material) on a timely basis or has received a valid
extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective
dates, the SEC Reports complied in all material respects with the required of the Securities Act and the Exchange Act, as applicable,
and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading. The consolidated financial statements and notes of LiveOne and its Subsidiaries for the year ended March 31, 2022, as
filed by LiveOne with the SEC (the “LiveOne Financials”), comply in all material respects with applicable accounting requirements
and the rules and regulations of the SEC with respect hereto as in effect at the time of filing, and fairly present in all material respects
the financial position and the results of operations, changes in shareholders’ equity, and cash flows of LiveOne and its subsidiaries,
on a consolidated basis, at the respective dates of and for the periods referred to in such financial statements, all in accordance with
(i) GAAP methodologies applied on a consistent basis throughout the periods involved and (ii) Regulation S-X or Regulation S-K, as applicable
(except as may be indicated in the notes thereto and for the omission of notes and audit adjustments in the case of unaudited quarterly
financial statements to the extent permitted by Regulation S-X or Regulation S-K, as applicable).

 

(u) Except
as and to the extent reflected or reserved against in the LiveOne Financials and except as set forth on Schedule 4(u), the Company has
no outstanding Indebtedness (as defined below) in excess of $100,000 or any obligations of the type required to be reflected on a balance
sheet in accordance with GAAP that is not adequately reflected or reserved on or provided for in the LiveOne Financials. For purposes
of this Agreement: (a) “Indebtedness” means, with respect to the Company: (i) indebtedness for borrowed money; (ii) amounts
owing as deferred purchase price for property or services, including “earn-out” payments; (iii) indebtedness for borrowed money
evidenced by any note, bond, debenture, mortgage or other debt instrument or debt security; (iv) obligations under any interest rate,
currency or other hedging or similar agreement; (v) obligations under any performance bond, surety bond, letter of credit or similar instrument,
but only to the extent drawn or called as of such time; (vi) all liabilities secured by any lien or other encumbrance on the assets or
property owned or held by the Company; (vii) all equity holder loans and employee advances; (viii) all accrued (or earned) and unpaid
employee salaries and all accrued (or earned) and unpaid employee bonus payments related to any period of time prior to the date hereof;
(ix) any indebtedness guaranteed for which the Company is liable; and (x) all accrued and unpaid taxes of the Company and its predecessors,
related to any period of time prior to the date hereof. The Company has not, in violation of Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley”),
directly or indirectly, including through a Subsidiary (other than as permitted under Sarbanes-Oxley for depositary institutions), extended
or maintained credit, arranged for the extension of credit, or renewed an extension of credit, in the form of a personal loan to or for
any director or executive officer of the Company.

 

    13

     

    

 

(v) Except
as set forth on Schedule 4(v), the Company and the Subsidiaries own or lease all such properties as are necessary to the conduct of its
business as presently operated and as proposed to be operated. The Company and the Subsidiaries have good and marketable title in fee
simple to all real property and good and marketable title to all personal property owned by them, in each case free and clear of all Liens
except or such as do not (individually or in the aggregate) materially affect the business or prospects of the Company or the Subsidiaries.
Any real property and buildings held under lease or sublease by The Company and the Subsidiaries are held by them under valid, subsisting
and enforceable leases with such exceptions as are not material to, and do not interfere with, the use made and proposed to be made of
such property and buildings by the Company and the Subsidiaries, except where the failure to have such lease would not reasonably be expected
to have, individually or in the aggregate, a Material Adverse Change. Neither the Company nor the Subsidiaries has received any notice
of any claim adverse to its ownership of any real or personal property or of any claim against the continued possession of any real property,
whether owned or held under lease or sublease by the Company or the Subsidiaries, except where the failure to have such lease would not
reasonably be expected to have, individually or in the aggregate, a Material Adverse Change.

 

(w) The
Company and the Subsidiaries: (i) own or possess adequate right to use all patents, patent applications, trademarks, service marks, trade
names, trademark registrations, service mark registrations, copyrights, licenses, formulae, customer lists, and know-how and other intellectual
property (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures,
“Intellectual Property”) necessary for the conduct of their respective businesses as currently operated and as proposed to
be operated and (ii) have no knowledge that the conduct of their respective businesses do or will conflict with, and they have not received
any notice of any claim of conflict with, any such right of others, except to the extent that the failure to own or possess or have adequate
rights to own, possess or have such Intellectual Property would not, individually or in the aggregate, reasonably be expected to have
a Material Adverse Change. To the Company’s knowledge, there is no infringement by third parties of any such Intellectual Property;
there is no pending or threatened action, suit, proceeding or claim by others challenging the Company’s or any Subsidiary’s
rights in or to any such Intellectual Property, and the Company is unaware of any facts which would form a reasonable basis for any such
claim; and there is no pending or, to the Company’s knowledge, threatened action, suit, proceeding or claim by others that the Company
or any Subsidiary infringes or otherwise violates any patent, trademark, copyright, trade secret or other proprietary rights of others,
and the Company is unaware of any other fact which would form a reasonable basis for any such claim, except in each case as would not
be expected, individually or in the aggregate, to have a Material Adverse Effect. Neither the Company nor any Subsidiary has received
any claim for royalties or other compensation from individuals, including employees or former employees of the Company, who made inventive
contributions to Company’s technology or products that are pending or unsettled, and, neither the Company nor the Subsidiaries will
have any obligation to pay royalties or other compensation to such individuals on account of inventive contributions, except for any claim
as would not be expected to have a Material Adverse Effect.

 

(x) Except
as set forth on Schedule 4(x) and the transactions contemplated in connection with the Spin-Out, to securities of the Company have been
sold by the Company or by or on behalf of, or for the benefit of, any person or persons controlling, controlled by, or under common control
with the Company since July 1, 2020, the date of LiveOne’s purchase of the Company.

 

    14

     

    

 

(y) Each
of the Company and the Subsidiaries has accurately prepared and timely filed all federal, state, foreign and other tax returns that are
required to be filed by it prior to the date hereof or has duly obtained extensions of time for the filing thereof and has paid or made
provision for the payment of all taxes, assessments, governmental or other similar charges, including without limitation, all sales and
use taxes and all taxes which the Company or any Subsidiary is obligated to withhold from amounts owing to employees, creditors and third
parties, with respect to the periods covered by such tax returns (whether or not such amounts are shown as due on any tax return), except
for any failure to file or obtain an extension or make a provision of the payment of taxes which would not reasonably be expected to result
in a Material Adverse Effect. No deficiency assessment with respect to a proposed adjustment of the Company’s or any Subsidiary’s
federal, state, local or foreign taxes is pending or, to the Company’s knowledge, threatened, except for any assessment which would
not reasonably be expected to result in a Material Adverse Change. The accruals and reserves on the books and records of the Company and
the Subsidiaries in respect of tax liabilities for any taxable period not finally determined are adequate to meet any assessments and
related liabilities for any such period consistent with GAAP and, since the date of LiveOne’s most recent financial statements filed
with the SEC. The Company and the Subsidiaries have not incurred any liability for taxes other than in the ordinary course of its business.
There is no tax lien, whether imposed by any federal, state, foreign or other taxing authority, outstanding against the assets, properties
or business of the Company or any Subsidiary. No transaction, stamp or other issuance or transfer taxes or duties, and no capital gain,
income transfer, withholder or other tax or duty is payable in the United States by or on behalf of the subscribers to any taxing authority
thereof or therein in connection with (i) the issuance, sale and delivery of the Securities by the Company; (ii) the holding or transfer
of the Securities; or (iii) the execution and delivery of this Subscription Agreement or any other document to be furnished hereunder.

 

(z) No
labor disturbance or dispute by or with the employees of the Company or the Subsidiaries, which, individually or in the aggregate, would
reasonably be expected to have a Material Adverse Effect, currently exists or, to the Company’s knowledge, is threatened. The Company
and the Subsidiaries are in compliance in all material respects with the labor and employment laws and collective bargaining agreements
and extension orders applicable to their employees in the United States.

 

(aa) Except as
would not be expected, individually or in the aggregate, to have a Material Adverse Effect, the Company and the Subsidiaries have at all
times operated their respective businesses in material compliance with all Environmental Laws, and no material expenditures are or will
be required in order to comply therewith. Neither the Company nor any Subsidiary has received any notice or communication that relates
to or alleges any actual or potential violation or failure to comply with any Environmental Laws that would individually or in the aggregate,
result in a Material Adverse Effect. As used herein, the term “Environmental Laws” means all applicable laws and regulations,
including any licensing, permits or reporting requirements, and any action by a federal, state, local or foreign government entity pertaining
to the protection of the environment, protection of public health, protection of worker health and safety, or the handling of hazardous
materials, including without limitation, the Clean Air Act, 42 U.S.C. § 7401, et seq., the Comprehensive Environmental Response,
Compensation and Liability Act of 1980, 42 U.S.C. § 9601, et seq., the Federal Water Pollution Control Act, 33 U.S.C. § 1321,
et seq., the Hazardous Materials Transportation Act, 49 U.S.C. § 1801, et seq., the Resource Conservation and Recovery Act, 42 U.S.C.
§ 690-1, et seq., and the Toxic Substances Control Act, 15 U.S.C. § 2601, et seq.

 

(bb) Each employment,
severance or other similar agreement, arrangement or policy and each material plan or arrangement providing for insurance coverage (including
any self-insured arrangements), workers’ compensation, disability benefits, severance benefits, supplemental unemployment benefits,
vacation benefits, retirement benefits or for deferred compensation, profit-sharing, bonuses, stock options, stock appreciation or other
forms of incentive compensation, or post-retirement insurance, compensation or benefits which: (i) is entered into, maintained or contributed
to, as the case may be, by the Company and (ii) covers any officer or director or former officer or director of the Company (collectively,
the “Benefit Arrangements”) have each been maintained in substantial compliance with its terms and with requirements prescribed
by any and all statutes, orders, rules and regulations that are applicable to that Benefit Arrangement, except for any failure which would
not reasonably be expected to result in a Material Adverse Effect.

 

    15

     

    

 

(cc) None of
the execution of this Subscription Agreement, the Notes, the Warrants, or consummation of this Offering and the transaction contemplated
by the Offering will constitute a triggering event under any employee plan or any other employment contract, whether or not legally enforceable,
which (either alone or upon the occurrence of any additional or subsequent event) will or may result in any payment (of severance pay
or otherwise), acceleration, increase in vesting, or increase in benefits to any current or former participant, employee or director of
the Company or any Subsidiary other than an event which would not, individually or in aggregate, reasonably be expected to result in a
Material Adverse Effect.

 

(dd) Neither
the Company, any Subsidiary nor, to the Company’s knowledge, any of their respective employees or agents has at any time during
the last five (5) years: (i) made any unlawful contribution to any candidate for domestic or foreign office, or failed to disclose fully
any contribution in violation of law, or (ii) made any payment to any foreign, federal or state governmental officer or official or Person
charged with similar public or quasi-public duties in the United States, other than payments that are not prohibited by the laws of the
United States or any jurisdiction thereof.

 

(ee) The Company
has not offered the Securities to any Person or entity with the intention of unlawfully influencing: (i) a customer or supplier of the
Company or any Subsidiary to alter the customer’s or supplier’s level or type of business with the Company or any Subsidiary
or (ii) a journalist or publication to write or publish favorable information about the Company, any Subsidiary or its products or services.

 

(ff) As of the
date hereof and as of the closing of this Subscription Agreement, and except as contemplated by this Subscription Agreement, neither the
Company nor any Subsidiary operates within the United States or any state or territory thereof in such a manner so as to subject the Company
or its operations or businesses to registration as a foreign company doing business in any state within the United States in a way which
would violate any of the following laws in any material respect: (i) the Bank Secrecy Act, as amended, (ii) the Uniting and Strengthening
of America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001, as amended, (iii) the Foreign Corrupt
Practices Act of 1977, as amended, (iv) the Currency and Foreign Transactions Reporting Act of 1970, as amended, (v) the Employee Retirement
Income Security Act of 1974, as amended, (vi) the Money Laundering Control Act of 1986, as amended, (vii) the rules and regulations promulgated
under any such law, or any successor law, or any judgment, decree or order of any applicable administrative or judicial body relating
to such law, and (viii) any corresponding law, rule, regulation, ordinance, judgment, decree or order of any state or territory of the
United States or any administrative or judicial body thereof.

 

(gg) The operations
of the Company and the Subsidiaries are and have been conducted at all times in compliance with applicable financial record keeping and
reporting requirements and money laundering statutes of the United States, and, to the Company’s knowledge, all other jurisdictions
to which the Company and the Subsidiaries are subject, the rules and regulations thereunder and any related or similar rules, regulations
or guidelines, issued, administered or enforced by any applicable governmental agency, including the Currency and Foreign Transactions
Reporting Act of 1970, as amended (collectively, the “Money Laundering Laws”) and no action, suit or proceeding by or before
any court or governmental agency, authority or body or any arbitrator involving the Company or any of the Subsidiaries with respect to
the Money Laundering Laws is pending or, to the best knowledge of the Company, threatened.

 

    16

     

    

 

(hh) Neither
the Company nor, to the knowledge of the Company, any director, officer, agent, employee or Affiliate of the Company is currently subject
to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”); and the
Company will not directly or indirectly use the proceeds of this offering, or lend, contribute or otherwise make available such proceeds
to any joint venture partner or other person or entity, for the purpose of financing the activities of any person currently subject to
any U.S. sanctions administered by OFAC.

 

(ii) None
of the Company, the Subsidiaries or their respective directors or officers or, to the knowledge of the Company, any agent, employee, affiliate
or other person acting on behalf of the Company or any of the Subsidiaries has engaged in any activities sanctionable under the Comprehensive
Iran Sanctions, Accountability, and Divestment Act of 2010, the Iran Sanctions Act of 1996, the National Defense Authorization Act for
Fiscal Year 2012, the Iran Threat Reduction and Syria Human Rights Act of 2012 or any Executive Order relating to any of the foregoing
(collectively, and as each may be amended from time to time, the “Iran Sanctions”); and the Company will not directly or indirectly
use the proceeds of this offering, or lend, contribute or otherwise make available such proceeds to any Subsidiary, joint venture partner
or other person or entity, for the purpose of engaging in any activities sanctionable under the Iran Sanctions.

 

(jj) Except for
payments due to the Placement Agent there are no contracts, agreements or understandings between the Company and any Person that would
give rise to a valid claim against the Company or any subscriber for a brokerage commission, finder’s fee, financial consulting
fee or other like payment in connection with the transactions contemplated by this Subscription Agreement or any arrangements, agreements,
understandings, payments or issuance with respect to the Company or any of its officers, directors, shareholders, partners, employees,
Subsidiaries or Affiliates that may affect the Placement Agent’s compensation as determined by Financial Industry Regulatory Authority,
Inc. (“FINRA”). The Company has not made any direct or indirect payments (in cash, securities or otherwise) to: (i) any person,
as a finder’s fee, consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing to
the Company persons who raised or provided capital to the Company; (ii) to any FINRA member; or (iii) to any person or entity that has
any direct or indirect affiliation or association with any FINRA member, within the 180 days prior to the Effective Date, other than the
prior payment of $25,000 to the Placement Agent in connection with this Offering. None of the net proceeds of this Offering will be paid
by the Company to any participating FINRA member or its affiliates, except as specifically authorized herein. No officer, director or
any beneficial owner of the Company’s securities (whether debt or equity, registered or unregistered, regardless of the time acquired
or the source from which derived) (any such individual or entity, a “Company Affiliate”) has any direct or indirect affiliation
or association with any FINRA member (as determined in accordance with the rules and regulations of FINRA); no Company Affiliate is an
owner of stock or other securities of any member of FINRA (other than securities purchased on the open market); no Company Affiliate has
made a subordinated loan to any member of FINRA; and no proceeds from the sale of Securities (excluding compensation owed to the Placement
Agent) will be paid to any FINRA member, or any persons associated with or affiliated with any member of FINRA. No FINRA member participating
in the offering has a conflict of interest with the Company. For this purpose, a “conflict of interest” exists when a member
of FINRA and/or its associated persons, parent or affiliates in the aggregate beneficially own 10% or more of the Company’s outstanding
subordinated debt or common equity, or 10% or more of the Company’s preferred equity. “FINRA member participating in the offering”
includes any associated person of a FINRA member that is participating in the offering, any member of such associated person’s immediate
family and any affiliate of a FINRA member that is participating in this offering.

 

    17

     

    

 

(kk) As used
in this Subscription Agreement, references to matters being “material” with respect to the Company or the Subsidiaries shall
mean a material event, change, condition, status or effect related to the condition (financial or otherwise), properties, assets (including
intangible assets), liabilities, business, prospects, operations or results of operations of the Company or the Subsidiaries, either individually
or taken as a whole, as the context requires.

 

(ll) As used
in this Subscription Agreement, the term “knowledge of the Company” (or similar language) shall mean the knowledge of the
executive officers and directors of the Company and the Subsidiaries, with the assumption that such executive officers and directors shall
have made reasonable and diligent inquiry of the matters presented (with reference to what is customary and prudent for the applicable
individuals in connection with the discharge by the applicable individuals of their duties as executive officers, directors or managers
of the Company or its applicable Subsidiary).

 

(mm) Neither
the Company, any of the Subsidiaries nor any of its properties or assets has any immunity from the jurisdiction of any court or from any
legal process (whether through service or notice, attachment to prior judgment, attachment in aid of execution or otherwise) under the
laws of the United States.

 

(nn) The capitalization
of the Company is as set forth on Schedule 4(oo).

 

(oo) The
Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as the board of directors of the Company has determined, in their good faith business judgment, to be necessary or prudent, including,
but not limited to, customary directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the
Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such
coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant
increase in cost.

 

(pp) The Company
and the board of directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business
combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company’s
certificate of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable
to the subscribers as a result of the subscribers and the Company fulfilling their obligations or exercising their rights under this Subscription
Agreement and the Other Transaction Documents, including without limitation as a result of the Company’s issuance of the Securities
and the subscribers’ ownership of the Securities.

 

    18

     

    

 

(qq) Based on
the consolidated financial condition of the Company as of the closing of this Subscription Agreement, after giving effect to the receipt
by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company’s assets exceeds
the amount that will be required to be paid on or in respect of the Company’s existing debts and other liabilities (including known
contingent liabilities) as they mature, (ii) the Company’s assets do not constitute unreasonably small capital to carry on its business
as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements of
the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) except
as set forth on Schedule 4(qq), the current cash flow of the Company, together with the proceeds the Company would receive, were it to
liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or
in respect of its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability
to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). The
Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under
the bankruptcy or reorganization laws of any jurisdiction within one (1) year from closing of this Subscription Agreement. Schedule
4(qq) sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for
which the Company or any Subsidiary has commitments.

 

(rr) The Company
acknowledges and agrees that each of the subscribers is acting solely in the capacity of an arm’s length subscriber with respect
to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges that no subscriber is acting
as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this Subscription Agreement or the Other
Transaction Documents and the transactions contemplated thereby and any advice given by any subscriber or any of their respective representatives
or agents in connection with this Subscription Agreement or the Other Transaction Documents and the transactions contemplated thereby
is merely incidental to the subscribers’ purchase of the Securities. The Company further represents to each subscriber that the
Company’s decision to enter into this Subscription Agreement and the Other Transaction Documents has been based solely on the independent
evaluation of the transactions contemplated hereby by the Company and its representatives.

 

(ss) Neither
the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities by any form of general solicitation
or general advertising. The Company has offered the Securities for sale only to the subscribers and certain other “accredited investors”
within the meaning of Rule 501 under the Securities Act.

 

(tt) With respect
to the Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities Act, none of the Company, any of its predecessors,
any affiliated issuer, any director, executive officer, other officer of the Company participating in the offering hereunder, any beneficial
owner of 20% or more of the Company’s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter
(as that term is defined in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of sale (each, an
“Issuer Covered Person”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i)
to (viii) under the Securities Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2)
or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event.
The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the subscribers
a copy of any disclosures provided thereunder.

 

    19

     

    

 

(uu) The Company
will notify the subscribers in writing, prior to the closing of this Subscription Agreement of (i) any Disqualification Event relating
to any Issuer Covered Person and (ii) any event that would, with the passage of time, reasonably be expected to become a Disqualification
Event relating to any Issuer Covered Person, in each case of which it is aware.

 

(vv) From the
date hereof until six (6) months after the end of the Lock-Up Period, neither the Company nor any Subsidiary shall issue, enter into any
agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, except for
an Excluded Issuance (as defined in the Warrant); provided, that the Company shall be permitted to announce or consummate any private
or public offering of any of its securities at a price per security that is effectively higher than the offering price per security in
the Qualified Financing or Qualified Event, as applicable.

 

(ww) From the
date hereof until twelve (12) months after the end of the Lock-Up period, the Company shall be prohibited from effecting or entering into
an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination
of units thereof) involving a Variable Rate Transaction except for an Excluded Issuance (as defined in the Warrant). “Variable
Rate Transaction” means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible
into, exchangeable or exercisable for, or include the right to receive, additional shares of Common Stock at a conversion price, exercise
price or exchange rate or other price that is based upon, and/or varies with, the trading prices of or quotations for the shares of Common
Stock at any time after the initial issuance of such debt or equity securities, or (ii) enters into, or effects a transaction under, any
agreement, including, but not limited to, an equity line of credit, whereby the Company may issue securities at a future determined price.
Any Subscriber shall be entitled to obtain injunctive relief against the Company to preclude any such issuance (except for an Excluded
Issuance), which remedy shall be in addition to any right to collect damages.

 

(xx) The
Company has never been an issuer subject to Rule 144(i) under the Securities Act.

 

(yy) Until the
Notes are paid or converted in full as provided in the Notes, the Company shall maintain on deposit in one or more of its accounts with
a US incorporated bank or a US branch of a non-US incorporated bank, $3,000,000 of Free Cash, less the amount of the principal balance
owed under the Notes that has been paid or repaid by the Company from time to time; provided that the foregoing shall not apply if the
Majority Noteholders (other than the Parent) (i) determine that it is in the best interests of the Company to maintain less than the required
amount of Free Cash, and (ii) provide a written consent. “Free Cash” means unencumbered, unrestricted cash of the Company
(other than as set forth under the Transaction Documents) on deposit in one or more bank accounts of the Company as determined by the
Company in its sole discretion.

 

    20

     

    

 

(zz) LiveOne
shall not effect any Qualified Financing or Qualified Event unless (i) the Company’s post-money valuation at the time of the Qualified
Event is at least $150 million and (ii) immediately following such event LiveOne owns no less than 66% of the Company’s equity,
unless in either case otherwise permitted by the written consent of the Majority Noteholders excluding the Parent.

 

(aaa) Until the
Qualified Financing or Qualified Event, as applicable, is consummated, LiveOne shall irrevocably and unconditionally guarantee to the
Subscribers and their respective successors, indorsees, transferees and assigns, the prompt and complete repayment when due (whether at
the stated maturity, by acceleration or otherwise, subject to any cure period) of the Notes (other than the Notes issued to LiveOne) and
any interest or other fees due thereunder, without presentment, protest, notice of protest, notice of non-payment, or any other notice
whatsoever. LiveOne has received any and all consents that are required to effectuate the foregoing.

 

(bbb) If the
Company has not consummated the Qualified Financing or Qualified Event, as applicable, by the seven-, eight- or nine-month anniversary
of the Initial Closing date, unless in either case permitted by the written consent of the Majority Noteholders excluding LiveOne, the
Company shall redeem $1,000,000 of the total principal amount of the then outstanding Notes (other than the Notes issued to LiveOne) by
the tenth calendar day of each month immediately following such respective anniversary date (provided, that if such date is not a Business
Day, such repayment shall be made on the immediately following Business Day), and an aggregate redemption of $3,000,000 over the course
of three such months, each of which shall be distributed to the holders of such Notes on a prorated basis. The Company has received any
and all consents that are required to effectuate the foregoing. In the event of any such redemption, the holders of the redeemed Notes
shall not forfeit any of their Warrants solely as a result of such redemption.

 

The foregoing representations
and warranties are true and accurate as of the date of closing of this Subscription Agreement. If, in any respect, those representations
and warranties shall not be true and accurate at the time of closing of this Subscription Agreement, the Company shall immediately give
written notice to the Placement Agent specifying which representations and warranties are not true and accurate and the reason therefor.
In such event, the Company and the Placement Agent shall determine if it then becomes necessary to amend or supplement the Executive Summary
or this Subscription Agreement so that the representations and warranties herein remain true and correct in all material respects, and
in such case, the Subscriber will promptly receive such an amendment or supplement prior to the closing of this Subscription Agreement.

 

    21

     

    

 

5. Rule
144 Issuances; Registration Statement.

 

(a) Rule
144 Issuances. If at any time, beginning one hundred and eighty (180) days from the date of issuance of the Warrants, Rule 144 under
the Securities Act (“Rule 144”) can be relied upon by the Subscriber with respect to its sale of the Warrant Shares (hereinafter
in this Section 5, the “Registrable Securities”) without the requirement for the Company to be in compliance with the current
public information required under Rule 144 as to such Registrable Securities and without volume or manner-of-sale restrictions, then the
Company shall cause certificates evidencing such Registrable Securities to be issued without any legend, other than any lock-up or other
restrictive legend required under this Subscription Agreement, the Notes, the Warrant, or the Other Transaction Documents. The Company
shall cause its counsel at its sole expense (or at Subscriber’s option, counsel selected by Subscriber and at the sole expense of
Subscriber) to issue a legal opinion to the Company’s transfer agent (the “Transfer Agent”) or the Subscriber promptly
if required by the Transfer Agent to effect the removal of the legend hereunder, or if requested by the Subscriber, respectively. If such
Registrable Securities may be sold under Rule 144 without the requirement for the Company to be in compliance with the current public
information required under Rule 144 as to such Registrable Securities and without volume or manner-of-sale restrictions or if such legend
is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued
by the staff of the Securities and Exchange Commission) then such Registrable Securities shall be issued free of all legends, other than
any lock-up or other restrictive legend required under this Subscription Agreement, the Notes, the Warrant, or the Other Transaction Documents.
The Company agrees that following such time as such legend is no longer required under this Section 5, it will, no later than the later
of (i) two (2) Trading Days (as defined below) and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
below) following the delivery by the Subscriber to the Company or the Transfer Agent of a certificate representing Registrable Securities,
as applicable, issued with a restrictive legend (such date, the “Legend Removal Date”), deliver or cause to be delivered to
the Subscriber a certificate representing such Registrable Securities that is free from all restrictive and other legends, other than
any lock-up or other restrictive legend required under this Subscription Agreement, the Notes, the Warrant, or the Other Transaction Documents.
The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer
set forth in this Section 5, other than any lock-up or other restrictive legend required under this Subscription Agreement, the Notes,
the Warrant, or the Other Transaction Documents. Certificates for Registrable Securities subject to legend removal hereunder (after the
removal of all lock-up or other restrictive legend required under this Subscription Agreement, the Notes, the Warrant, or the Other Transaction
Documents) shall be transmitted by the Transfer Agent to the Subscriber by crediting the account of the Subscriber’s prime broker
with the Depository Trust Company System as directed by the Subscriber. As used herein, “Standard Settlement Period” means
the standard settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect to the
Shares as in effect on the date of delivery of a certificate representing Registrable Securities, as applicable, issued with a restrictive
legend. As used herein, “Trading Day” means a day on which the principal Trading Market is open for trading. As used herein,
“Trading Market” means any of the following markets or exchanges on which the Company’s Shares is listed or quoted for
trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market,
or the New York Stock Exchange (or any successors to any of the foregoing).

 

(b) While
the Note is outstanding, in addition to such Subscriber’s other available remedies, the Company shall pay to a Subscriber, in cash,
as partial liquidated damages and not as a penalty, two percent (2%) of such Subscriber’s subscription amount for each month after
the Legend Removal Date until such certificate is delivered without a legend; provided, that any such damages shall not accrue or be payable
whatsoever to the extent that (i) any such delay arises from or in connection with a Subscriber’s failure to timely deliver all
materials and documents reasonably requested by the Company, its legal counsel and/or its transfer agent, or (ii) Subscriber’s broker’s
inability, refusal or any other reason to permit the removal of the legend.

 

    22

     

    

 

(c) At
any time during the period that the Note is outstanding, commencing on the twelve (12) month anniversary of the date hereof (or the fifteen
(15) month anniversary of such date, if the maturity date of the Note is extended pursuant to the terms therein) and ending at such time
that all of the Securities may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without
restriction or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information
requirement under Rule 144(c) or (ii) during the period that the Note is outstanding, has ever been an issuer described in Rule 144 (i)(1)(i)
or becomes an issuer, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a “Public Information
Failure”) then, in addition to such Subscriber’s other available remedies, the Company shall pay to a Subscriber, in cash,
as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell the Securities,
an amount in cash equal to one percent (1.0%) of the aggregate Subscription Amount of such Subscriber’s Securities on the day of
a Public Information Failure and on every thirtieth (30th) day (pro rated for periods totaling less than thirty days) thereafter
until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information is no longer
required for the Subscribers to transfer the Warrant Shares and Conversion Shares pursuant to Rule 144, provided that such liquidated
damages shall not exceed in the aggregate to twelve percent (12.0%) of such Subscriber’s aggregate Subscription Amount.  The
payments to which a Subscriber shall be entitled pursuant to this Section 4.3(b) are referred to herein as “Public Information
Failure Payments.”  Public Information Failure Payments shall be paid on the earlier of (i) the last day of the calendar
month during which such Public Information Failure Payments are incurred and (ii) the third (3rd) Business Day after the event
or failure giving rise to the Public Information Failure Payments is cured.  In the event the Company fails to make Public Information
Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated
for partial months) until paid in full. Nothing herein shall limit such Subscriber’s right to pursue actual damages for the Public
Information Failure, and such Subscriber shall have the right to pursue all remedies available to it at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief. Upon Subscriber’s redemption of any Notes in accordance with
Section 2(d) of the Note, then a portion of the Subscriber’s Warrants shall be forfeited and cancelled in accordance with the following
formula: for each $1,000 of Principal Amount (as such term is defined in the Note) of Notes redeemed, Warrants to purchase 100% of the
Warrant Shares issued per $1,000 of Principal Amount shall be immediately forfeited and cancelled and the Holder shall not have any right
to any payments under this Section 5 with respect to such canceled Warrants or redeemed Notes.

 

(d) Registration
Statement. On or prior to the date that is nine (9) months after the date of the Initial Closing, the Company shall use its commercially
reasonable best efforts to prepare and file with the SEC a Registration Statement on Form S-1 (or such other form as applicable) covering,
among other securities, the resale under the Securities Act of the shares of Company’s common stock underlying the Securities for an offering
to be made on a continuous basis pursuant to Rule 415 (the “Registration Statement”). The Company shall use its commercially
reasonable best efforts to cause the Registration Statement to be declared effective promptly thereafter on or before the Notes’
maturity date (as may be extended). If the Company does not file the Registration Statement on or prior to the date that is nine (9) months
after the Initial Closing, the Company shall prepay $1,000,000 of the principal amount of the Notes pro rata to the Note holders (other
than LiveOne). If the Company does not file the Registration Statement on or prior to the date that is twelve (12) months after the Initial
Closing, the Company shall prepay $2,000,000 of the principal amount of the Notes pro rata to the Note holders (other than LiveOne). For
the avoidance of doubt, the Company’s and/or LiveOne’s obligations pursuant to this Section 5(d) shall not be in addition
to the obligations described in Section 4(bbb) of this Subscription Agreement, such that the maximum aggregate redemption and/or prepayment
amount required to be paid by the Company and/or LiveOne pursuant to this Section 5(d) and Section 4(bbb) shall be $3,000,000.

 

    23

     

    

 

6. Indemnification.
The Subscriber acknowledges that it understands the meaning and legal consequences of the representations, warranties and covenants in
paragraph 3 hereof and that the Company has relied upon such representations, warranties and covenants, and he hereby agrees to indemnify
and hold harmless the Company, LiveOne and the Placement Agent and their respective officers, directors, controlling persons, agents,
representatives, managers, employees, affiliates, successors and assigns (collectively, the “Representatives”), from and against
any and all losses, damages or liabilities due to or arising out of a breach of any representation, warranty, agreement, obligation or
covenant made by the Subscriber herein. Notwithstanding the foregoing, however, no representation, warranty, covenant, acknowledgment
or agreement made herein by the Subscriber shall in any manner be deemed to constitute a waiver of any rights granted to the Subscriber
under Federal or state securities laws. All representations, warranties and covenants contained in this Subscription Agreement and the
indemnification contained in this paragraph 6 shall survive the acceptance of this subscription.

 

7. Restrictions
on Transfer. The Subscriber understands and agrees that, in addition to the provisions regarding restrictions on withdrawal and
transferability of his investment contained in the securities comprising the Units, the following restriction and limitation is applicable
to the Subscriber’s investment in the Units pursuant to Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D promulgated
thereunder: The Notes, Warrants, the Conversion Shares, and the Warrant Shares shall (i) not be sold, pledged, hypothecated or otherwise
transferred unless they are registered under the Securities Act and applicable state securities laws or are exempt therefrom, and (ii)
shall be subject to the market stand-off legend and restrictions as set forth in the Notes and the Warrants.

 

8. Investor
Qualification. The Subscriber previously or simultaneously herewith has furnished a completed and executed Confidential Subscriber
Questionnaire, the information in which is true and correct in all respects and which is hereby incorporated by reference herein.

 

9. Modification.
Neither this Subscription Agreement nor any provision hereof shall be waived, modified, changed, discharged or terminated except by an
instrument in writing signed by the party against whom any waiver, modification, change, discharge or termination is sought to be enforced.

 

10. Notices.
All notices, requests, consents and other communications hereunder shall be in writing and shall be deemed to have been duly made when
delivered, or mailed by registered or certified mail, return receipt requested:

 

(a) If
to the Subscriber, to the address set forth on the signature page of this Subscription Agreement; or

 

(b) If
to the Company, to the address set forth on the first page of this Subscription Agreement; or

 

(c) At
such other address as the Subscriber or the Company may hereafter have advised the other by a notice conforming with this paragraph 8.

 

    24

     

    

 

11. Binding
Effect. Except as otherwise provided herein, this Subscription Agreement shall be binding upon and inure to the benefit of the
parties hereto and their heirs, executors, administrators, successors, legal representatives and assigns. If the Subscriber is more than
one person, the obligation of such Subscriber shall be joint and several and the agreements, representations, warranties, covenants and
acknowledgments herein contained shall be deemed to be made by and be binding upon each such person and his or its heirs, executors, administrators,
successors, legal representatives and assigns.

 

12. Third
Party Beneficiaries. The Placement Agent shall be deemed a third party beneficiary of the representations and warranties of the
Subscriber contained in Section 3 hereof and the Company as contained in Section 4 hereof and shall have the right to enforce such provisions
directly to the extent it may deem such enforcement necessary or advisable to protect its rights.

 

13. Entire
Agreement. This Subscription Agreement, together with the Note, the Warrant and the NDA (if applicable), contains the entire agreement
of the parties with respect to the matters set forth herein and there are no representations, covenants or other agreements except as
stated or referred to herein or as are embodied in the Notes and the Warrants.

 

14. Assignability.
This Subscription Agreement, and the rights, interests and obligations hereunder, are not transferable or assignable by the undersigned
or any successor thereto.

 

15. Applicable
Law. This Subscription Agreement shall be governed by and construed in accordance with the laws of the State of New York, without
reference to the principles thereof relating to the conflict of laws.

 

16. Arbitration.
The parties agree to submit all controversies relating to the subject matter of this Subscription Agreement to arbitration in accordance
with the provisions set forth below and understand that:

 

Arbitration is
final and binding on the parties.

 

The parties are waiving their right
to seek remedies in court, including the right to a jury trial. Pre-arbitration discovery is generally more limited and different from
court proceedings.

 

The arbitrator’s award is not required
to include factual findings or legal reasoning and any party’s right to appeal or to seek modification of rulings by arbitrators is strictly
limited.

 

The panel of arbitrators will typically
include a minority of arbitrators who were or are affiliated with the securities industry.

 

All controversies which may arise between
the parties concerning this Subscription Agreement shall be determined by arbitration pursuant to the rules then pertaining to the Financial
Industry Regulatory Authority, Inc. in New York, New York. Judgment on any award of any such arbitration may be entered in the Supreme
Court of the State of New York or in any other court having jurisdiction of the Person or Persons against whom such award is rendered.
Any notice of such arbitration or for the confirmation of any award in any arbitration shall be sufficient if given in accordance with
the provisions of this Subscription Agreement. The parties agree that the determination of the arbitrators shall be binding and conclusive
upon them.

 

    25

     

    

 

17. Confidentiality;
Certain Disclosures. The Company will use their best efforts to keep the information provided in the Confidential Subscriber Questionnaire
strictly confidential. The Company may present this Subscription Agreement and the information provided in the Confidential Subscriber
Questionnaire to such parties as they deem advisable if compelled by law or called upon to establish the availability under any Federal
or state securities laws of an exemption from registration of the offering or if the contents thereof are relevant to any issue in any
action, suit, or proceeding to which the Manager or the Company is a party or by which it is or may be bound.

 

18. Use
of Proceeds. The net proceeds of the offering shall be used for working capital requirement and general corporate purposes.

 

19. Miscellaneous.

 

(a) Each
of the parties hereto shall pay its own fees and expenses (including the fees of any attorneys, accountants, appraisers or others engaged
by such party) in connection with this Subscription Agreement and the transactions contemplated hereby whether or not the transactions
contemplated hereby are consummated.

 

(b) This
Subscription Agreement may be executed in one or more counterparts each of which shall be deemed an original (including signatures sent
by facsimile transmission or by email transmission of a PDF scanned document), but all of which shall together constitute one and the
same instrument.

 

(c) Each
provision of this Subscription Agreement shall be considered separable and, if for any reason any provision or provisions hereof are determined
to be invalid or contrary to applicable law, such invalidity or illegality shall not impair the operation of or affect the remaining portions
of this Subscription Agreement.

 

(d) Paragraph
titles are for descriptive purposes only and shall not control or alter the meaning of this Subscription Agreement as set forth in the
text.

 

(e) All
terms used in any one number or gender in this Subscription Agreement shall be extended to mean and include any other number and gender
as the facts, context or sense of this Subscription Agreement may require.

 

(f)  The
Company will disclose Confidential Information to the Subscriber to permit the completion of this Offering on the terms of this Subscription
Agreement. The foregoing Section 19(f) shall not apply to any Subscriber who has executed a separate non-disclosure agreement with the
Company and/or LiveOne (an “NDA”), and the terms of such NDA shall apply instead to the Confidential Information disclosed
by the Company to such Subscriber.

 

    26

     

    

 

Each party agrees
that: (i) it will not disclose the other party’s Confidential Information to any person or make use of or take advantage of the
other party’s Confidential Information for any purpose other than as expressly permitted by this document; (ii) it will take all
steps necessary to ensure that the other party’s Confidential Information is kept confidential; (iii) it will not copy the other
party’s Confidential Information or permit the copying of the other party’s Confidential Information in any form other than
as permitted by the other party; (iv) upon request, it will return a party’s Confidential Information to that party, together with
any copies of that party’s Confidential Information; and (v) it will not make use of the other party’s Confidential Information
in any manner so as to obtain any benefit, right or privilege for itself or for any other person that would not have been available but
for it having access to the Confidential Information except as permitted by this document. “Confidential Information” means:
(A) all information, whether written, oral, electronic or in any other form provided (before or after the date of this document) by the
Company, LiveOne or any of their respective Representatives relating to the Company’s, LiveOne’s and/or any of their affiliates’
operations, affairs and/or business including without limitation know how, trade secrets, intellectual property rights, business, corporate
or trade information; (B) all analyses, compilations, forecasts, studies or other documents prepared by any party which contain or reflect
any such information; (C) the existence and content of and negotiations with respect to this Subscription Agreement, the Notes, the Warrants
and the Other Transaction Documents; (D) the existence of this Offering and other potential transactions relating to the operations, affairs
and business of the Company, LiveOne or any of their respective Representatives; and (E) any information which would, under the circumstances,
appear to a reasonable person to be confidential or proprietary. Confidential Information may include information of a third party that
is in the possession of the Company, LiveOne and/or any of their respective Representatives and is disclosed to the Subscriber or its
Representatives in connection with this Subscription Agreement. The parties also acknowledge and agree that any analyses, compilations,
studies or other embodiments or derivatives of Confidential Information prepared by the Subscriber or its Representatives (or anyone to
whom the Subscriber or its Representatives disclose such Confidential Information) shall be owned solely by the Company and/or LiveOne,
as applicable, and treated as Confidential Information of the Company and/or LiveOne, as applicable.

 

Confidential Information
shall not include any information which: (i) at the time of disclosure is in the public domain or thereafter becomes part of the public
domain through no fault of the Subscriber or any of its Representatives; (ii) the Subscriber can establish that the Subscriber was in
its possession prior to the time of disclosure without violation of the Company’s or LiveOne’s rights under this Subscription
Agreement, (iii) is independently made available to the Subscriber by a third party who is not thereby in violation of a confidential
or fiduciary relationship with the Subscriber and without violation of the Company’s or LiveOne’s rights under this Subscription
Agreement; or (iv) the Subscriber can conclusively establish that it was independently developed by the Subscriber without use of or reference
to the Confidential Information.

 

The Subscriber may
disclose any Confidential Information pursuant to the order or requirement of a court, administrative agency, or other governmental body;
provided, however, that the Subscriber shall provide prior prompt written notice of such court order or requirement to the Company and
LiveOne to enable the Company and LiveOne to seek a protective order or otherwise prevent or restrict such disclosure. Notwithstanding
the foregoing, the Subscriber will be permitted to disclose, with such written notice as is reasonable under the circumstances (which
notice will be prior to disclosure if reasonable under the circumstances), the Confidential Information or any portion thereof as required
by federal or state securities laws or upon the request of any government, regulatory or self-regulatory body having or claiming authority
to regulate or oversee any aspect of the Subscriber’s business or that of its affiliates, but the Subscriber agrees, where applicable,
to advise them of the confidential nature of such information and request confidential treatment of such information. Such disclosed information
shall continue to be treated as Confidential Information and shall be subject to the terms of this Subscription Agreement.

 

(g) The
Subscriber will not, and will not permit any of Subscriber’s Representatives or any person under Subscriber’s control or influence
(including any Representative) to, make a public statement, press release or other communication announcing this Offering or any terms
hereof or any transactions contemplated hereunder before the Company has announced this Offering.

 

    27

     

    

 

ANTI MONEY LAUNDERING REQUIREMENTS

 

	
    The USA PATRIOT Act
	What is money laundering?	How big is the problem and why is it important?
	
    The USA PATRIOT Act is designed to detect, deter, and punish terrorists
    in the United States and abroad. The Act imposes new anti-money laundering requirements on brokerage firms and financial institutions.
    Since April 24, 2002 all brokerage firms have been required to have new, comprehensive anti-money laundering programs.

     

    To help you understand these efforts, the Placement Agent wants to
    provide you with some information about money laundering and its steps to implement the USA PATRIOT Act.
	Money laundering is the process of disguising illegally obtained money so that the funds appear to come from legitimate sources or activities, Money laundering occurs in connection with a wide variety of crimes, including illegal arms sales, drug trafficking, robbery, fraud, racketeering, and terrorism.	The use of the U.S. financial system by criminals to facilitate terrorism or other crimes could well taint our financial markets. According to the U.S. State Department, one recent estimate puts the amount of worldwide money laundering activity at $1 trillion a year.

 

	As part of the Placement Agent’s required program, it may ask you to provide various identification documents or other information. Until you provide the information or documents the Placement Agent needs, it may not be able to effect any transactions for you.

                                                                                 

	What are we required to do to eliminate money laundering?

                                                                                 

	Under rules required by the USA PATRIOT Act, the Placement Agent’s anti-money laundering program must designate a special compliance officer, set up employee training, conduct independent audits, and establish policies and procedures to detect and report suspicious transaction and ensure compliance with such laws.	 

 

    28

     

    

 

IN WITNESS WHEREOF, the undersigned
has executed this Subscription Agreement as of the ________ day of __________, 2022

 

Number of Units Subscribed for at $100,000 per
Unit: ________________________

 

Dollar Amount of Units Subscribed for $ ________________________

 

If the Subscriber is a NATURAL PERSON, purchased
as an INDIVIDUAL, as JOINT TENANTS, as TENANTS IN COMMON, or as COMMUNITY PROPERTY by more than one individual:

 

	 	 	 
	 	 	(Signature of Subscriber)
	 	 	 
	 	 	 
	 	 	(Name Typed or Printed)
	 	 	 
	 	 	 
	 	 	(Signature of Co-Subscriber)
	 	 	 
	 	 	 
	 	 	(Name Typed or Printed)
	 	 	 
	 	 	 
	Mailing Address	 	Residence Address
	(if not residence)	 	 
	 	 	 
	 	 	 
	City, State and Zip Code	 	City, State and Zip Code
	 	 	 
	 	 	 
	Social Security Number of Subscriber	 	 
	 	 	 
	 	 	 
	Social Security Number of Co-Subscriber	 	 

 

    29

     

    

 

IN WITNESS WHEREOF, the undersigned has executed
this Subscription Agreement as of the _______ day of ______________, 2022.

 

Number of Units Subscribed for at $100,000 per Unit: _____________________________ 

 

Dollar Amount of Units Subscribed for $ _____________________________

 

If the Subscriber is an ENTITY:

 

Type of Ownership: (Check One)

 

____ Corporation

____ Limited Partnership

____ General Partnership

____ Limited Liability Company

____ Limited Liability Partnership

____ Revocable Trust

____ Irrevocable Trust

____ Tax Exempt Organization

____ Estate

____ Other (specify)  _________________________________

 

	 	 	 
	 	 	Name of Entity (Print)
	 	 	 
	 	 	 
	 	 	Signature of Subscriber’s Authorized Signatory
	 	 	 
	 	 	 
	 	 	Name of Subscriber’s Authorized Signatory (Print)
	 	 	 
	 	 	 
	Principal Business Mailing Address	 	Title of Authorized Signatory (Print)
	 	 	 
	 	 	 
	City, State and Zip Code	 	Federal Tax Identification Number

 

    30

     

    

 

Accepted as of the 15th day of July.

 

	 	July 15, 2022
	 	 
	 	Courtside Group, Inc.
	 	 
	 	By:	                 
	 	Name:	 
	 	Title:	 
	 	 	 
	 	July 15, 2022
	 	 
	 	LiveOne, Inc., solely as guarantor pursuant to Section 4(aaa) of this Subscription Agreement.
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 

 

 

Joseph Gunnar & Co., LLC

[for internal use only]

 

[Signature Page to Courtside Group, Inc. Subscription
Agreement]

 

 

31

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}]]